https://bordet.makemeweb.dev/fr/esmo-clinical-research-observatory-ecro-improving-efficiency-clinical-research-through 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/esmo-clinical-research-observatory-ecro-improving-efficiency-clinical-research-through 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/late-effects-adjuvant-chemotherapy-adumbrate-dormancy-complexity-breast-cancer 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/late-effects-adjuvant-chemotherapy-adumbrate-dormancy-complexity-breast-cancer 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/late-effects-adjuvant-chemotherapy-adumbrate-dormancy-complexity-breast-cancer 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/regorafenib-after-failure-gemcitabine-and-platinum-based-chemotherapy-locally-advancedmetastatic 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/regorafenib-after-failure-gemcitabine-and-platinum-based-chemotherapy-locally-advancedmetastatic 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/regorafenib-after-failure-gemcitabine-and-platinum-based-chemotherapy-locally-advancedmetastatic 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/ersestseactsestro-guidelines-management-malignant-pleural-mesothelioma-0 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/ersestseactsestro-guidelines-management-malignant-pleural-mesothelioma-0 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/ersestseactsestro-guidelines-management-malignant-pleural-mesothelioma-0 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/supportive-care-do-we-need-model 2020-09-07T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/adjuvant-therapy-pegylated-interferon-alfa2b-vs-observation-stage-ii-bc-patients-ulcerated-primary 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/adjuvant-therapy-pegylated-interferon-alfa2b-vs-observation-stage-ii-bc-patients-ulcerated-primary 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/adjuvant-therapy-pegylated-interferon-alfa2b-vs-observation-stage-ii-bc-patients-ulcerated-primary 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/efficacy-and-toxicity-immune-checkpoint-inhibitors-patients-preexisting-autoimmune-disorders 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/efficacy-and-toxicity-immune-checkpoint-inhibitors-patients-preexisting-autoimmune-disorders 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/efficacy-and-toxicity-immune-checkpoint-inhibitors-patients-preexisting-autoimmune-disorders 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/application-risk-management-framework-integration-stromal-tumor-infiltrating-lymphocytes-clinical 2024-03-31T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/application-risk-management-framework-integration-stromal-tumor-infiltrating-lymphocytes-clinical 2024-03-31T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/application-risk-management-framework-integration-stromal-tumor-infiltrating-lymphocytes-clinical 2024-03-31T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/external-validation-briganti-nomogram-predicting-lymph-node-invasion-patients-intermediate-and-high 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/external-validation-briganti-nomogram-predicting-lymph-node-invasion-patients-intermediate-and-high 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/external-validation-briganti-nomogram-predicting-lymph-node-invasion-patients-intermediate-and-high 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/esmo-management-and-treatment-adapted-recommendations-covid-19-era-breast-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/esmo-management-and-treatment-adapted-recommendations-covid-19-era-breast-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/esmo-management-and-treatment-adapted-recommendations-covid-19-era-breast-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/expanding-landscape-actionable-genomic-alterations-metastatic-breast-cancer-comprehensive-genomic 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/expanding-landscape-actionable-genomic-alterations-metastatic-breast-cancer-comprehensive-genomic 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/expanding-landscape-actionable-genomic-alterations-metastatic-breast-cancer-comprehensive-genomic 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/pitfalls-assessing-stromal-tumor-infiltrating-lymphocytes-stils-breast-cancer 2024-03-31T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/pitfalls-assessing-stromal-tumor-infiltrating-lymphocytes-stils-breast-cancer 2024-03-31T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/pitfalls-assessing-stromal-tumor-infiltrating-lymphocytes-stils-breast-cancer 2024-03-31T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/triggered-imaging-auto-beam-hold-and-pre-posttreatment-cbct-during-prostate-sabr-analysis-time 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/fr/triggered-imaging-auto-beam-hold-and-pre-posttreatment-cbct-during-prostate-sabr-analysis-time 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/nl/triggered-imaging-auto-beam-hold-and-pre-posttreatment-cbct-during-prostate-sabr-analysis-time 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/en/follow-head-and-neck-cancer-survivors-tipping-balance-intensity 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/follow-head-and-neck-cancer-survivors-tipping-balance-intensity 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/follow-head-and-neck-cancer-survivors-tipping-balance-intensity 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/adenosine-pathway-immuno-oncology 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/adenosine-pathway-immuno-oncology 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/adenosine-pathway-immuno-oncology 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/clinical-effect-computed-guided-pudendal-nerve-block-patients-premature-ejaculation-pilot-study 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/clinical-effect-computed-guided-pudendal-nerve-block-patients-premature-ejaculation-pilot-study 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/clinical-effect-computed-guided-pudendal-nerve-block-patients-premature-ejaculation-pilot-study 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/peace-v-salvage-treatment-oligorecurrent-nodal-prostate-cancer-metastases-storm-study-protocol 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/peace-v-salvage-treatment-oligorecurrent-nodal-prostate-cancer-metastases-storm-study-protocol 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/peace-v-salvage-treatment-oligorecurrent-nodal-prostate-cancer-metastases-storm-study-protocol 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/anti-her2-therapy-breast-cancer-older-patients 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/anti-her2-therapy-breast-cancer-older-patients 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/anti-her2-therapy-breast-cancer-older-patients 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/report-computational-assessment-tumor-infiltrating-lymphocytes-international-immuno-oncology 2024-03-31T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/report-computational-assessment-tumor-infiltrating-lymphocytes-international-immuno-oncology 2024-03-31T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/report-computational-assessment-tumor-infiltrating-lymphocytes-international-immuno-oncology 2024-03-31T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/comparison-laparoscopic-splenectomy-outcomes-benign-and-malignant-hemopathies 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/fr/comparison-laparoscopic-splenectomy-outcomes-benign-and-malignant-hemopathies 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/nl/comparison-laparoscopic-splenectomy-outcomes-benign-and-malignant-hemopathies 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/en/phylogenetic-reconstruction-breast-cancer-reveals-two-routes-metastatic-dissemination-associated 2024-04-14T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/phylogenetic-reconstruction-breast-cancer-reveals-two-routes-metastatic-dissemination-associated 2024-04-14T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/phylogenetic-reconstruction-breast-cancer-reveals-two-routes-metastatic-dissemination-associated 2024-04-14T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/metabolic-reprogramming-metastatic-melanoma-acquired-resistance-targeted-therapies-integrative 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/metabolic-reprogramming-metastatic-melanoma-acquired-resistance-targeted-therapies-integrative 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/metabolic-reprogramming-metastatic-melanoma-acquired-resistance-targeted-therapies-integrative 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/deep-learning-approach-predicting-breast-tumor-response-neoadjuvant-treatment-using-dce-mri-volumes 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/deep-learning-approach-predicting-breast-tumor-response-neoadjuvant-treatment-using-dce-mri-volumes 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/deep-learning-approach-predicting-breast-tumor-response-neoadjuvant-treatment-using-dce-mri-volumes 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/predict-breast-tumor-response-chemotherapy-using-3d-deep-learning-architecture-applied-dce-mri-data 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/predict-breast-tumor-response-chemotherapy-using-3d-deep-learning-architecture-applied-dce-mri-data 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/predict-breast-tumor-response-chemotherapy-using-3d-deep-learning-architecture-applied-dce-mri-data 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/impact-68ga-psma-petct-treatment-prostate-cancer-initial-experience-spain 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/impact-68ga-psma-petct-treatment-prostate-cancer-initial-experience-spain 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/impact-68ga-psma-petct-treatment-prostate-cancer-initial-experience-spain 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/phase-ii-open-label-study-investigating-apalutamide-patients-biochemical-progression-after-radical 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/phase-ii-open-label-study-investigating-apalutamide-patients-biochemical-progression-after-radical 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/phase-ii-open-label-study-investigating-apalutamide-patients-biochemical-progression-after-radical 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/stereotactic-robotic-body-radiotherapy-patients-oligorecurrent-pulmonary-metastases 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/fr/stereotactic-robotic-body-radiotherapy-patients-oligorecurrent-pulmonary-metastases 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/nl/stereotactic-robotic-body-radiotherapy-patients-oligorecurrent-pulmonary-metastases 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/en/espen-guideline-home-parenteral-nutrition 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/espen-guideline-home-parenteral-nutrition 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/espen-guideline-home-parenteral-nutrition 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/use-chimerism-analysis-after-allogeneic-stem-cell-transplantation-belgian-guidelines-and-review 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/use-chimerism-analysis-after-allogeneic-stem-cell-transplantation-belgian-guidelines-and-review 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/use-chimerism-analysis-after-allogeneic-stem-cell-transplantation-belgian-guidelines-and-review 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/laparoscopic-treatment-pudendal-nerve-and-artery-entrapment-improves-erectile-dysfunction-healthy 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/laparoscopic-treatment-pudendal-nerve-and-artery-entrapment-improves-erectile-dysfunction-healthy 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/laparoscopic-treatment-pudendal-nerve-and-artery-entrapment-improves-erectile-dysfunction-healthy 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/fgf2-induces-resistance-nilotinib-through-mapk-pathway-activation-kit-mutated-melanoma 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/fgf2-induces-resistance-nilotinib-through-mapk-pathway-activation-kit-mutated-melanoma 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/fgf2-induces-resistance-nilotinib-through-mapk-pathway-activation-kit-mutated-melanoma 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/hpv-involvement-tumor-microenvironment-and-immune-treatment-head-and-neck-squamous-cell-carcinomas 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/hpv-involvement-tumor-microenvironment-and-immune-treatment-head-and-neck-squamous-cell-carcinomas 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/hpv-involvement-tumor-microenvironment-and-immune-treatment-head-and-neck-squamous-cell-carcinomas 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/what-validity-self-reported-fractures 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/what-validity-self-reported-fractures 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/what-validity-self-reported-fractures 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/use-granulocyte-colony-stimulating-factors-older-patients-review-recently-published-data-0 2020-09-07T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/effect-covid-19-pandemic-cancer-treatment-and-research 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/effect-covid-19-pandemic-cancer-treatment-and-research 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/effect-covid-19-pandemic-cancer-treatment-and-research 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/colon-adenocarcinoma-associated-clostridium-septicum-endophthalmitis-detected-18f-fdg-petct 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/colon-adenocarcinoma-associated-clostridium-septicum-endophthalmitis-detected-18f-fdg-petct 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/colon-adenocarcinoma-associated-clostridium-septicum-endophthalmitis-detected-18f-fdg-petct 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/underevaluation-fractures-self-report-analysis-frisbee-cohort 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/underevaluation-fractures-self-report-analysis-frisbee-cohort 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/underevaluation-fractures-self-report-analysis-frisbee-cohort 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/important-considerations-prior-elimination-breast-cancer-surgery-after-neoadjuvant-systemic-therapy 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/important-considerations-prior-elimination-breast-cancer-surgery-after-neoadjuvant-systemic-therapy 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/important-considerations-prior-elimination-breast-cancer-surgery-after-neoadjuvant-systemic-therapy 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/importance-des-shunt-lympho-veineux-chez-des-patientes-avec-un-oedeme-des-membres-inferieurs-prpops 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/importance-des-shunt-lympho-veineux-chez-des-patientes-avec-un-oedeme-des-membres-inferieurs-prpops 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/importance-des-shunt-lympho-veineux-chez-des-patientes-avec-un-oedeme-des-membres-inferieurs-prpops 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/high-total-metabolic-tumor-volume-baseline-predicts-survival-independent-response-therapy 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/fr/high-total-metabolic-tumor-volume-baseline-predicts-survival-independent-response-therapy 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/nl/high-total-metabolic-tumor-volume-baseline-predicts-survival-independent-response-therapy 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/en/tumor-sequencing-useful-refine-analysis-germline-variants-unexplained-high-risk-breast-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/tumor-sequencing-useful-refine-analysis-germline-variants-unexplained-high-risk-breast-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/tumor-sequencing-useful-refine-analysis-germline-variants-unexplained-high-risk-breast-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/ai-reading-screening-mammograms-need-circumspection 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/ai-reading-screening-mammograms-need-circumspection 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/ai-reading-screening-mammograms-need-circumspection 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/prognostic-value-patient-reported-health-related-quality-life-and-geriatric-assessment-predicting 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/prognostic-value-patient-reported-health-related-quality-life-and-geriatric-assessment-predicting 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/prognostic-value-patient-reported-health-related-quality-life-and-geriatric-assessment-predicting 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/sepsis-and-septic-shock-patients-malignancies-groupe-de-recherche-respiratoire-en-reanimation-onco 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/sepsis-and-septic-shock-patients-malignancies-groupe-de-recherche-respiratoire-en-reanimation-onco 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/sepsis-and-septic-shock-patients-malignancies-groupe-de-recherche-respiratoire-en-reanimation-onco 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/colour-sidedness-gloucester-cattle-associated-complex-structural-variant-impacting-regulatory 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/colour-sidedness-gloucester-cattle-associated-complex-structural-variant-impacting-regulatory 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/colour-sidedness-gloucester-cattle-associated-complex-structural-variant-impacting-regulatory 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/inflammation-alters-secretome-and-immunomodulatory-properties-human-skin-derived-precursor-cells 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/inflammation-alters-secretome-and-immunomodulatory-properties-human-skin-derived-precursor-cells 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/inflammation-alters-secretome-and-immunomodulatory-properties-human-skin-derived-precursor-cells 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/q-fever-associated-granulomatous-hepatitis 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/q-fever-associated-granulomatous-hepatitis 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/q-fever-associated-granulomatous-hepatitis 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/vulval-intestinalenteric-heterotopia-patient-crohn-s-disease 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/vulval-intestinalenteric-heterotopia-patient-crohn-s-disease 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/vulval-intestinalenteric-heterotopia-patient-crohn-s-disease 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/immunotherapy-advanced-nsclc-early-stages-evolving-concept 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/immunotherapy-advanced-nsclc-early-stages-evolving-concept 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/immunotherapy-advanced-nsclc-early-stages-evolving-concept 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/imaging-and-clinical-correlates-regorafenib-metastatic-colorectal-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/imaging-and-clinical-correlates-regorafenib-metastatic-colorectal-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/imaging-and-clinical-correlates-regorafenib-metastatic-colorectal-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/how-does-physicians-decisional-conflict-influence-their-ability-address-treatment-outcomes-decision 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/how-does-physicians-decisional-conflict-influence-their-ability-address-treatment-outcomes-decision 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/how-does-physicians-decisional-conflict-influence-their-ability-address-treatment-outcomes-decision 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/adjuvant-chemotherapy-biliary-tract-cancer-patients-systematic-review-and-meta-analysis-randomized 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/adjuvant-chemotherapy-biliary-tract-cancer-patients-systematic-review-and-meta-analysis-randomized 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/adjuvant-chemotherapy-biliary-tract-cancer-patients-systematic-review-and-meta-analysis-randomized 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/computed-tomography-based-analyses-baseline-body-composition-parameters-and-changes-breast-cancer 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/computed-tomography-based-analyses-baseline-body-composition-parameters-and-changes-breast-cancer 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/computed-tomography-based-analyses-baseline-body-composition-parameters-and-changes-breast-cancer 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/role-direct-oral-anticoagulants-management-cancerassociated-thrombosis 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/role-direct-oral-anticoagulants-management-cancerassociated-thrombosis 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/role-direct-oral-anticoagulants-management-cancerassociated-thrombosis 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/prognostic-and-predictive-impact-beta-2-adrenergic-receptor-expression-her2-positive-breast-cancer 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/prognostic-and-predictive-impact-beta-2-adrenergic-receptor-expression-her2-positive-breast-cancer 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/prognostic-and-predictive-impact-beta-2-adrenergic-receptor-expression-her2-positive-breast-cancer 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/post-traumatic-bone-granuloma-caused-retained-foreign-bodies 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/post-traumatic-bone-granuloma-caused-retained-foreign-bodies 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/post-traumatic-bone-granuloma-caused-retained-foreign-bodies 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/optimum-imaging-chronic-pancreatitis 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/optimum-imaging-chronic-pancreatitis 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/optimum-imaging-chronic-pancreatitis 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/safety-and-efficacy-immune-checkpoint-inhibitors-advanced-urological-cancers-pre-existing 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/safety-and-efficacy-immune-checkpoint-inhibitors-advanced-urological-cancers-pre-existing 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/safety-and-efficacy-immune-checkpoint-inhibitors-advanced-urological-cancers-pre-existing 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/lurbinectedin-second-line-treatment-patients-small-cell-lung-cancer-single-arm-open-label-phase-2 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/lurbinectedin-second-line-treatment-patients-small-cell-lung-cancer-single-arm-open-label-phase-2 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/lurbinectedin-second-line-treatment-patients-small-cell-lung-cancer-single-arm-open-label-phase-2 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/lessons-learned-sabcs-2019-and-dos-immunotherapy-breast-cancer 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/lessons-learned-sabcs-2019-and-dos-immunotherapy-breast-cancer 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/lessons-learned-sabcs-2019-and-dos-immunotherapy-breast-cancer 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/inflammatory-hepatocellular-adenoma-focal-nodular-hyperplasia-and-hepatic-granulomas-one-single 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/inflammatory-hepatocellular-adenoma-focal-nodular-hyperplasia-and-hepatic-granulomas-one-single 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/inflammatory-hepatocellular-adenoma-focal-nodular-hyperplasia-and-hepatic-granulomas-one-single 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/radiotherapy-quality-assurance-head-and-neck-squamous-cell-carcinoma 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/radiotherapy-quality-assurance-head-and-neck-squamous-cell-carcinoma 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/radiotherapy-quality-assurance-head-and-neck-squamous-cell-carcinoma 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/monte-carlo-dose-calculations-shielding-disks-different-material-combinations-intraoperative 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/monte-carlo-dose-calculations-shielding-disks-different-material-combinations-intraoperative 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/monte-carlo-dose-calculations-shielding-disks-different-material-combinations-intraoperative 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/guidelines-optimal-management-malignant-colorectal-polyp-what-essential-pathology-report 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/guidelines-optimal-management-malignant-colorectal-polyp-what-essential-pathology-report 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/guidelines-optimal-management-malignant-colorectal-polyp-what-essential-pathology-report 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/personalized-selective-internal-radiation-therapy-liver-metastasis-thyroid-cancer-impaired-liver 2024-03-31T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/personalized-selective-internal-radiation-therapy-liver-metastasis-thyroid-cancer-impaired-liver 2024-03-31T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/personalized-selective-internal-radiation-therapy-liver-metastasis-thyroid-cancer-impaired-liver 2024-03-31T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/long-term-cardiac-outcomes-patients-her2-positive-breast-cancer-treated-adjuvant-lapatinib-andor 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/long-term-cardiac-outcomes-patients-her2-positive-breast-cancer-treated-adjuvant-lapatinib-andor 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/long-term-cardiac-outcomes-patients-her2-positive-breast-cancer-treated-adjuvant-lapatinib-andor 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/legacy-professor-aron-goldhirsch 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/legacy-professor-aron-goldhirsch 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/legacy-professor-aron-goldhirsch 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/cancer-du-sein-avec-metastase-inhabituelle-au-niveau-vesical-rapport-de-cas-et-revue-systematique 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/cancer-du-sein-avec-metastase-inhabituelle-au-niveau-vesical-rapport-de-cas-et-revue-systematique 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/cancer-du-sein-avec-metastase-inhabituelle-au-niveau-vesical-rapport-de-cas-et-revue-systematique 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/triple-negative-breast-cancer-current-treatment-and-future-perspectives 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/triple-negative-breast-cancer-current-treatment-and-future-perspectives 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/triple-negative-breast-cancer-current-treatment-and-future-perspectives 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/role-direct-oral-anticoagulants-management-cancer-associated-thrombosis 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/role-direct-oral-anticoagulants-management-cancer-associated-thrombosis 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/role-direct-oral-anticoagulants-management-cancer-associated-thrombosis 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/technologist-s-guide-radiopharmacy-update-chapter-2-theoretical-basics-radiopharmacy-zena-wimana-18 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/technologist-s-guide-radiopharmacy-update-chapter-2-theoretical-basics-radiopharmacy-zena-wimana-18 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/technologist-s-guide-radiopharmacy-update-chapter-2-theoretical-basics-radiopharmacy-zena-wimana-18 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/pooled-crispr-inverse-pcr-sequencing-pcip-seq-simultaneous-sequencing-retroviral-insertion-points 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/pooled-crispr-inverse-pcr-sequencing-pcip-seq-simultaneous-sequencing-retroviral-insertion-points 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/pooled-crispr-inverse-pcr-sequencing-pcip-seq-simultaneous-sequencing-retroviral-insertion-points 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/adult-t-cell-leukaemia-lymphoma-pathogeny-and-clinical-recommendations 2024-04-14T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/adult-t-cell-leukaemia-lymphoma-pathogeny-and-clinical-recommendations 2024-04-14T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/adult-t-cell-leukaemia-lymphoma-pathogeny-and-clinical-recommendations 2024-04-14T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/stress-incertitude-resilience-et-ruptures-dans-l-adaptation-d-razavi-n-delvaux-eds-psycho-oncologie 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/stress-incertitude-resilience-et-ruptures-dans-l-adaptation-d-razavi-n-delvaux-eds-psycho-oncologie 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/stress-incertitude-resilience-et-ruptures-dans-l-adaptation-d-razavi-n-delvaux-eds-psycho-oncologie 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/comportement-tabagique-impact-et-sevrage-d-razavi-n-delvaux-eds-psycho-oncologie-concepts 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/comportement-tabagique-impact-et-sevrage-d-razavi-n-delvaux-eds-psycho-oncologie-concepts 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/comportement-tabagique-impact-et-sevrage-d-razavi-n-delvaux-eds-psycho-oncologie-concepts 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/traitements-psychopharmacologiques-d-razavi-n-delvaux-eds-psycho-oncologie-concepts-theoriques 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/traitements-psychopharmacologiques-d-razavi-n-delvaux-eds-psycho-oncologie-concepts-theoriques 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/traitements-psychopharmacologiques-d-razavi-n-delvaux-eds-psycho-oncologie-concepts-theoriques 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/confusion-mentale-d-razavi-n-delvaux-eds-psycho-oncologie-concepts-theoriques-interventions 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/confusion-mentale-d-razavi-n-delvaux-eds-psycho-oncologie-concepts-theoriques-interventions 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/confusion-mentale-d-razavi-n-delvaux-eds-psycho-oncologie-concepts-theoriques-interventions 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/facteurs-de-risque-psychologiques-d-razavi-n-delvaux-eds-psycho-oncologie-concepts-theoriques 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/facteurs-de-risque-psychologiques-d-razavi-n-delvaux-eds-psycho-oncologie-concepts-theoriques 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/facteurs-de-risque-psychologiques-d-razavi-n-delvaux-eds-psycho-oncologie-concepts-theoriques 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/facteurs-de-risque-comportementaux-d-razavi-n-delvaux-eds-psycho-oncologie-concepts-theoriques 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/facteurs-de-risque-comportementaux-d-razavi-n-delvaux-eds-psycho-oncologie-concepts-theoriques 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/facteurs-de-risque-comportementaux-d-razavi-n-delvaux-eds-psycho-oncologie-concepts-theoriques 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/communication-soignant-soigne-generalites-d-razavi-n-delvaux-eds-psychooncologie-concepts 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/communication-soignant-soigne-generalites-d-razavi-n-delvaux-eds-psychooncologie-concepts 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/communication-soignant-soigne-generalites-d-razavi-n-delvaux-eds-psychooncologie-concepts 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/communication-soignant-soigne-problematiques-d-razavi-n-delvaux-eds-psycho-oncologie-concepts 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/communication-soignant-soigne-problematiques-d-razavi-n-delvaux-eds-psycho-oncologie-concepts 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/communication-soignant-soigne-problematiques-d-razavi-n-delvaux-eds-psycho-oncologie-concepts 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/interventions-psychologiques-d-razavi-n-delvaux-eds-psycho-oncologie-concepts-theoriques 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/interventions-psychologiques-d-razavi-n-delvaux-eds-psycho-oncologie-concepts-theoriques 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/interventions-psychologiques-d-razavi-n-delvaux-eds-psycho-oncologie-concepts-theoriques 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/formation-des-soignants-la-relation-et-la-communication-d-razavi-n-delvaux-eds-psycho-oncologie 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/formation-des-soignants-la-relation-et-la-communication-d-razavi-n-delvaux-eds-psycho-oncologie 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/formation-des-soignants-la-relation-et-la-communication-d-razavi-n-delvaux-eds-psycho-oncologie 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/mesures-de-l-efficacite-des-formations-la-communication-d-razavi-n-delvaux-eds-psycho-oncologie 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/mesures-de-l-efficacite-des-formations-la-communication-d-razavi-n-delvaux-eds-psycho-oncologie 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/mesures-de-l-efficacite-des-formations-la-communication-d-razavi-n-delvaux-eds-psycho-oncologie 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/stress-professionnel-et-burnout-des-soignants-d-razavi-n-delvaux-eds-psycho-oncologie-concepts 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/stress-professionnel-et-burnout-des-soignants-d-razavi-n-delvaux-eds-psycho-oncologie-concepts 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/stress-professionnel-et-burnout-des-soignants-d-razavi-n-delvaux-eds-psycho-oncologie-concepts 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/deuil-complications-et-prise-en-charge-d-razavi-n-delvaux-eds-psycho-oncologie-concepts-theoriques 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/deuil-complications-et-prise-en-charge-d-razavi-n-delvaux-eds-psycho-oncologie-concepts-theoriques 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/deuil-complications-et-prise-en-charge-d-razavi-n-delvaux-eds-psycho-oncologie-concepts-theoriques 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/decisions-de-fin-de-vie-d-razavi-n-delvaux-eds-psycho-oncologie-concepts-theoriques-interventions 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/decisions-de-fin-de-vie-d-razavi-n-delvaux-eds-psycho-oncologie-concepts-theoriques-interventions 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/decisions-de-fin-de-vie-d-razavi-n-delvaux-eds-psycho-oncologie-concepts-theoriques-interventions 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/prise-en-charge-de-la-douleur-d-razavi-n-delvaux-eds-psycho-oncologie-concepts-theoriques 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/prise-en-charge-de-la-douleur-d-razavi-n-delvaux-eds-psycho-oncologie-concepts-theoriques 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/prise-en-charge-de-la-douleur-d-razavi-n-delvaux-eds-psycho-oncologie-concepts-theoriques 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/interventions-destinees-la-famille-et-aux-proches-d-razavi-n-delvaux-eds-psycho-oncologie-concepts 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/interventions-destinees-la-famille-et-aux-proches-d-razavi-n-delvaux-eds-psycho-oncologie-concepts 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/interventions-destinees-la-famille-et-aux-proches-d-razavi-n-delvaux-eds-psycho-oncologie-concepts 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/communication-soignant-soigne-processus-d-annonce-de-mauvaises-nouvelles-d-razavi-n-delvaux-eds 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/communication-soignant-soigne-processus-d-annonce-de-mauvaises-nouvelles-d-razavi-n-delvaux-eds 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/communication-soignant-soigne-processus-d-annonce-de-mauvaises-nouvelles-d-razavi-n-delvaux-eds 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/enfants-face-au-cancer-d-un-parent-reactions-et-prise-en-charge-d-razavi-n-delvaux-eds-psycho 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/enfants-face-au-cancer-d-un-parent-reactions-et-prise-en-charge-d-razavi-n-delvaux-eds-psycho 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/enfants-face-au-cancer-d-un-parent-reactions-et-prise-en-charge-d-razavi-n-delvaux-eds-psycho 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/adaptation-de-la-famille-et-des-proches-d-razavi-n-delvaux-eds-psycho-oncologie-concepts-theoriques 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/adaptation-de-la-famille-et-des-proches-d-razavi-n-delvaux-eds-psycho-oncologie-concepts-theoriques 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/adaptation-de-la-famille-et-des-proches-d-razavi-n-delvaux-eds-psycho-oncologie-concepts-theoriques 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/troubles-cognitifs-d-razavi-n-delvaux-eds-psycho-oncologie-concepts-theoriques-interventions 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/troubles-cognitifs-d-razavi-n-delvaux-eds-psycho-oncologie-concepts-theoriques-interventions 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/troubles-cognitifs-d-razavi-n-delvaux-eds-psycho-oncologie-concepts-theoriques-interventions 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/adaptation-psychologique-au-diagnostic-et-aux-traitements-d-razavi-n-delvaux-eds-psycho-oncologie 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/adaptation-psychologique-au-diagnostic-et-aux-traitements-d-razavi-n-delvaux-eds-psycho-oncologie 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/adaptation-psychologique-au-diagnostic-et-aux-traitements-d-razavi-n-delvaux-eds-psycho-oncologie 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/concepts-theoriques-et-interventions-cliniques-elsevier-masson 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/concepts-theoriques-et-interventions-cliniques-elsevier-masson 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/concepts-theoriques-et-interventions-cliniques-elsevier-masson 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/le-psychotherapeute-au-pays-medicalise-des-patients-et-des-soignants 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/le-psychotherapeute-au-pays-medicalise-des-patients-et-des-soignants 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/le-psychotherapeute-au-pays-medicalise-des-patients-et-des-soignants 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/le-mythe-de-sisyphe-cancer-et-chronicite 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/le-mythe-de-sisyphe-cancer-et-chronicite 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/le-mythe-de-sisyphe-cancer-et-chronicite 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/features-evaluation-and-treatment-coronavirus-covid-19 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/features-evaluation-and-treatment-coronavirus-covid-19 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/features-evaluation-and-treatment-coronavirus-covid-19 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/head-and-neck-mri-only-radiotherapy-treatment-planning-acquisition-treatment-position-pseudo-ct 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/head-and-neck-mri-only-radiotherapy-treatment-planning-acquisition-treatment-position-pseudo-ct 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/head-and-neck-mri-only-radiotherapy-treatment-planning-acquisition-treatment-position-pseudo-ct 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/core-spliceosomal-factor-u2af1-controls-cell-fate-determination-modulation-transcriptional-networks 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/core-spliceosomal-factor-u2af1-controls-cell-fate-determination-modulation-transcriptional-networks 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/core-spliceosomal-factor-u2af1-controls-cell-fate-determination-modulation-transcriptional-networks 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/proliferative-fasciitis-hand-nine-year-old-girl-case-report-and-review-literature 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/proliferative-fasciitis-hand-nine-year-old-girl-case-report-and-review-literature 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/proliferative-fasciitis-hand-nine-year-old-girl-case-report-and-review-literature 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/frailty-score-older-patients-haematological-malignancies-unsuspected-role-mild-cognitive-impairment 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/fr/frailty-score-older-patients-haematological-malignancies-unsuspected-role-mild-cognitive-impairment 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/nl/frailty-score-older-patients-haematological-malignancies-unsuspected-role-mild-cognitive-impairment 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/en/nir-infrared-imaging-after-peritumoral-injection-indocyanine-green-guide-lymph-node-dissection-head 2024-03-31T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/nir-infrared-imaging-after-peritumoral-injection-indocyanine-green-guide-lymph-node-dissection-head 2024-03-31T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/nir-infrared-imaging-after-peritumoral-injection-indocyanine-green-guide-lymph-node-dissection-head 2024-03-31T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/do-recent-immigrants-have-similar-obstetrical-care-and-perinatal-complications-long-term-residents 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/do-recent-immigrants-have-similar-obstetrical-care-and-perinatal-complications-long-term-residents 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/do-recent-immigrants-have-similar-obstetrical-care-and-perinatal-complications-long-term-residents 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/impact-cell-expansion-and-inflammation-immune-biology-human-adipose-tissue-derived-mesenchymal 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/impact-cell-expansion-and-inflammation-immune-biology-human-adipose-tissue-derived-mesenchymal 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/impact-cell-expansion-and-inflammation-immune-biology-human-adipose-tissue-derived-mesenchymal 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/impact-cyclin-dependent-kinase-4-and-6-inhibitors-cdk46i-incidence-alopecia-patients-metastatic 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/impact-cyclin-dependent-kinase-4-and-6-inhibitors-cdk46i-incidence-alopecia-patients-metastatic 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/impact-cyclin-dependent-kinase-4-and-6-inhibitors-cdk46i-incidence-alopecia-patients-metastatic 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/standard-anthracycline-based-versus-docetaxel-capecitabine-early-high-clinical-andor-genomic-risk 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/standard-anthracycline-based-versus-docetaxel-capecitabine-early-high-clinical-andor-genomic-risk 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/standard-anthracycline-based-versus-docetaxel-capecitabine-early-high-clinical-andor-genomic-risk 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/cardiotoxicity-trastuzumab-given-12-months-compared-shorter-treatment-periods-systematic-review-and 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/cardiotoxicity-trastuzumab-given-12-months-compared-shorter-treatment-periods-systematic-review-and 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/cardiotoxicity-trastuzumab-given-12-months-compared-shorter-treatment-periods-systematic-review-and 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/osteoporosis-treatment-gap-prospective-cohort-volunteer-women 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/osteoporosis-treatment-gap-prospective-cohort-volunteer-women 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/osteoporosis-treatment-gap-prospective-cohort-volunteer-women 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/retrospective-analysis-immunogenic-effects-intra-arterial-locoregional-therapies-hepatocellular 2024-05-05T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/retrospective-analysis-immunogenic-effects-intra-arterial-locoregional-therapies-hepatocellular 2024-05-05T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/retrospective-analysis-immunogenic-effects-intra-arterial-locoregional-therapies-hepatocellular 2024-05-05T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/safety-and-efficacy-restarting-immune-checkpoint-inhibitors-after-clinically-significant-immune 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/safety-and-efficacy-restarting-immune-checkpoint-inhibitors-after-clinically-significant-immune 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/safety-and-efficacy-restarting-immune-checkpoint-inhibitors-after-clinically-significant-immune 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/chimeric-antigen-receptor-t-cell-therapy-b-cell-hematological-malignancies-update-pivotal-clinical 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/chimeric-antigen-receptor-t-cell-therapy-b-cell-hematological-malignancies-update-pivotal-clinical 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/chimeric-antigen-receptor-t-cell-therapy-b-cell-hematological-malignancies-update-pivotal-clinical 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/kinome-profiling-predict-sensitivity-mapk-inhibition-melanoma-and-provide-new-insights-intrinsic 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/kinome-profiling-predict-sensitivity-mapk-inhibition-melanoma-and-provide-new-insights-intrinsic 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/kinome-profiling-predict-sensitivity-mapk-inhibition-melanoma-and-provide-new-insights-intrinsic 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/early-modulation-circulating-micrornas-levels-her2-positive-breast-cancer-patients-treated 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/early-modulation-circulating-micrornas-levels-her2-positive-breast-cancer-patients-treated 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/early-modulation-circulating-micrornas-levels-her2-positive-breast-cancer-patients-treated 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/prognostic-value-three-scale-grading-system-based-combining-molecular-imaging-68ga-dotatate-and-18f 2024-03-10T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/fr/prognostic-value-three-scale-grading-system-based-combining-molecular-imaging-68ga-dotatate-and-18f 2024-03-10T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/nl/prognostic-value-three-scale-grading-system-based-combining-molecular-imaging-68ga-dotatate-and-18f 2024-03-10T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/en/path-better-biomarker-application-risk-management-framework-implementation-pd-l1-and-tils-immuno 2024-03-31T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/path-better-biomarker-application-risk-management-framework-implementation-pd-l1-and-tils-immuno 2024-03-31T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/path-better-biomarker-application-risk-management-framework-implementation-pd-l1-and-tils-immuno 2024-03-31T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/prophylactic-cranial-irradiation-pci-or-magnetic-resonance-imaging-mri-monitoring-limited-small 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/prophylactic-cranial-irradiation-pci-or-magnetic-resonance-imaging-mri-monitoring-limited-small 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/prophylactic-cranial-irradiation-pci-or-magnetic-resonance-imaging-mri-monitoring-limited-small 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/increasing-dose-intensity-chemotherapy-more-frequent-administration-or-sequential-scheduling 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/increasing-dose-intensity-chemotherapy-more-frequent-administration-or-sequential-scheduling 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/increasing-dose-intensity-chemotherapy-more-frequent-administration-or-sequential-scheduling 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/la-revue-medicale-de-bruxelles-se-met-la-page 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/la-revue-medicale-de-bruxelles-se-met-la-page 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/la-revue-medicale-de-bruxelles-se-met-la-page 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/les-reseaux-sociaux-une-place-pour-la-revue-medicale-de-bruxelles 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/les-reseaux-sociaux-une-place-pour-la-revue-medicale-de-bruxelles 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/les-reseaux-sociaux-une-place-pour-la-revue-medicale-de-bruxelles 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/editorial 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/editorial 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/editorial 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/biographie-et-revue-systematique-une-valeur-ajoutee 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/biographie-et-revue-systematique-une-valeur-ajoutee 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/biographie-et-revue-systematique-une-valeur-ajoutee 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/les-dependances-aux-substances-psychoactives-un-probleme-de-societe 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/les-dependances-aux-substances-psychoactives-un-probleme-de-societe 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/les-dependances-aux-substances-psychoactives-un-probleme-de-societe 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/paraneoplastic-hypercortisolism-case-report-and-review-available-therapeutic-options 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/paraneoplastic-hypercortisolism-case-report-and-review-available-therapeutic-options 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/paraneoplastic-hypercortisolism-case-report-and-review-available-therapeutic-options 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/2019-world-health-organization-classification-tumours-breast 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/2019-world-health-organization-classification-tumours-breast 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/2019-world-health-organization-classification-tumours-breast 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/significant-progress-non-small-cell-lung-cancers-durvalumab-consolidates-radiochemotherapy-locally 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/significant-progress-non-small-cell-lung-cancers-durvalumab-consolidates-radiochemotherapy-locally 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/significant-progress-non-small-cell-lung-cancers-durvalumab-consolidates-radiochemotherapy-locally 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/les-cancers-bronchiques-non-petites-cellules-oligometastatiques-definition-et-prise-en 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/les-cancers-bronchiques-non-petites-cellules-oligometastatiques-definition-et-prise-en 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/les-cancers-bronchiques-non-petites-cellules-oligometastatiques-definition-et-prise-en 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/what-real-impact-estrogen-receptor-status-prognosis-and-treatment-her2-positive-early-breast-cancer 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/what-real-impact-estrogen-receptor-status-prognosis-and-treatment-her2-positive-early-breast-cancer 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/what-real-impact-estrogen-receptor-status-prognosis-and-treatment-her2-positive-early-breast-cancer 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/atir101-administered-after-t-cell-depleted-haploidentical-hsct-reduces-nrm-and-improves-overall 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/atir101-administered-after-t-cell-depleted-haploidentical-hsct-reduces-nrm-and-improves-overall 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/atir101-administered-after-t-cell-depleted-haploidentical-hsct-reduces-nrm-and-improves-overall 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/molecular-subclasses-breast-cancer-how-do-we-define-them-impakt-2012-working-group-statement 2024-04-14T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/molecular-subclasses-breast-cancer-how-do-we-define-them-impakt-2012-working-group-statement 2024-04-14T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/molecular-subclasses-breast-cancer-how-do-we-define-them-impakt-2012-working-group-statement 2024-04-14T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/new-strategies-and-designs-pancreatic-cancer-research-consensus-guidelines-report-european-expert 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/new-strategies-and-designs-pancreatic-cancer-research-consensus-guidelines-report-european-expert 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/new-strategies-and-designs-pancreatic-cancer-research-consensus-guidelines-report-european-expert 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/advances-pain-management-older-patients-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/advances-pain-management-older-patients-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/advances-pain-management-older-patients-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/treatment-and-other-healthcare-use-breast-cancer-patients-previous-cancer-diagnosis 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/treatment-and-other-healthcare-use-breast-cancer-patients-previous-cancer-diagnosis 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/treatment-and-other-healthcare-use-breast-cancer-patients-previous-cancer-diagnosis 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/association-between-nuclear-cytoplasmic-ratio-p27-and-efficacy-adjuvant-polychemotherapy-early 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/fr/association-between-nuclear-cytoplasmic-ratio-p27-and-efficacy-adjuvant-polychemotherapy-early 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/nl/association-between-nuclear-cytoplasmic-ratio-p27-and-efficacy-adjuvant-polychemotherapy-early 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/en/genomic-grade-adds-prognostic-value-invasive-lobular-carcinoma 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/genomic-grade-adds-prognostic-value-invasive-lobular-carcinoma 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/genomic-grade-adds-prognostic-value-invasive-lobular-carcinoma 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/integration-m6-cyberknife-moderato-monte-carlo-platform-and-prediction-beam-parameters-using 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/integration-m6-cyberknife-moderato-monte-carlo-platform-and-prediction-beam-parameters-using 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/integration-m6-cyberknife-moderato-monte-carlo-platform-and-prediction-beam-parameters-using 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/international-standards-analysis-quality-life-and-patient-reported-outcome-endpoints-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/international-standards-analysis-quality-life-and-patient-reported-outcome-endpoints-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/international-standards-analysis-quality-life-and-patient-reported-outcome-endpoints-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/postfracture-risk-assessment-target-centrally-sited-fractures-first-substudy-nofract 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/postfracture-risk-assessment-target-centrally-sited-fractures-first-substudy-nofract 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/postfracture-risk-assessment-target-centrally-sited-fractures-first-substudy-nofract 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/immunotherapy-nonsmall-cell-lung-cancer-new-therapeutic-algorithm 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/immunotherapy-nonsmall-cell-lung-cancer-new-therapeutic-algorithm 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/immunotherapy-nonsmall-cell-lung-cancer-new-therapeutic-algorithm 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/management-chronic-testicular-pain-due-thoracolumbar-junction-syndrome-pilot-study 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/management-chronic-testicular-pain-due-thoracolumbar-junction-syndrome-pilot-study 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/management-chronic-testicular-pain-due-thoracolumbar-junction-syndrome-pilot-study 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/survey-belgian-practice-non-malignant-diseases 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/survey-belgian-practice-non-malignant-diseases 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/survey-belgian-practice-non-malignant-diseases 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/patient-reported-outcomes-and-genomic-signatures-tools-tailor-adjuvant-endocrine-treatment 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/patient-reported-outcomes-and-genomic-signatures-tools-tailor-adjuvant-endocrine-treatment 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/patient-reported-outcomes-and-genomic-signatures-tools-tailor-adjuvant-endocrine-treatment 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/estimating-benefits-therapy-early-stage-breast-cancer-st-gallen-international-consensus-guidelines 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/estimating-benefits-therapy-early-stage-breast-cancer-st-gallen-international-consensus-guidelines 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/estimating-benefits-therapy-early-stage-breast-cancer-st-gallen-international-consensus-guidelines 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/long-term-outcomes-patients-decompensated-alcohol-related-liver-disease-steatohepatitis-and-maddrey 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/long-term-outcomes-patients-decompensated-alcohol-related-liver-disease-steatohepatitis-and-maddrey 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/long-term-outcomes-patients-decompensated-alcohol-related-liver-disease-steatohepatitis-and-maddrey 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/management-cardiac-disease-cancer-patients-throughout-oncological-treatment-esmo-consensus 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/management-cardiac-disease-cancer-patients-throughout-oncological-treatment-esmo-consensus 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/management-cardiac-disease-cancer-patients-throughout-oncological-treatment-esmo-consensus 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/adjuvant-chemotherapy-rectal-cancer-current-evidence-and-recommendations-clinical-practice 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/adjuvant-chemotherapy-rectal-cancer-current-evidence-and-recommendations-clinical-practice 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/adjuvant-chemotherapy-rectal-cancer-current-evidence-and-recommendations-clinical-practice 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/trastuzumab-emtansine-t-dm1-associated-cardiotoxicity-pooled-analysis-advanced-her2-positive-breast 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/trastuzumab-emtansine-t-dm1-associated-cardiotoxicity-pooled-analysis-advanced-her2-positive-breast 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/trastuzumab-emtansine-t-dm1-associated-cardiotoxicity-pooled-analysis-advanced-her2-positive-breast 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/incidence-and-management-diarrhea-adjuvant-pertuzumab-and-trastuzumab-patients-human-epidermal 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/incidence-and-management-diarrhea-adjuvant-pertuzumab-and-trastuzumab-patients-human-epidermal 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/incidence-and-management-diarrhea-adjuvant-pertuzumab-and-trastuzumab-patients-human-epidermal 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/blue-painful-limb-cancer-patient 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/fr/blue-painful-limb-cancer-patient 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/nl/blue-painful-limb-cancer-patient 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/en/biomarkers-response-and-resistance-pi3k-inhibitors-estrogen-receptor-positive-breast-cancer 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/biomarkers-response-and-resistance-pi3k-inhibitors-estrogen-receptor-positive-breast-cancer 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/biomarkers-response-and-resistance-pi3k-inhibitors-estrogen-receptor-positive-breast-cancer 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/calcitonin-biomarker-c-cell-disease-recent-achievements-and-current-challenges 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/calcitonin-biomarker-c-cell-disease-recent-achievements-and-current-challenges 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/calcitonin-biomarker-c-cell-disease-recent-achievements-and-current-challenges 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/immune-checkpoint-inhibitor-induced-pancreatic-injury-imaging-findings-and-literature-review 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/immune-checkpoint-inhibitor-induced-pancreatic-injury-imaging-findings-and-literature-review 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/immune-checkpoint-inhibitor-induced-pancreatic-injury-imaging-findings-and-literature-review 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/breast-cancer-vaccines-heeding-lessons-past-guide-path-forward 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/breast-cancer-vaccines-heeding-lessons-past-guide-path-forward 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/breast-cancer-vaccines-heeding-lessons-past-guide-path-forward 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/reactive-stroma-and-trastuzumab-resistance-her2-positive-early-breast-cancer 2024-03-31T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/reactive-stroma-and-trastuzumab-resistance-her2-positive-early-breast-cancer 2024-03-31T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/reactive-stroma-and-trastuzumab-resistance-her2-positive-early-breast-cancer 2024-03-31T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/homologous-recombination-repair-deficiency-and-immune-response-breast-cancer-literature-review 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/homologous-recombination-repair-deficiency-and-immune-response-breast-cancer-literature-review 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/homologous-recombination-repair-deficiency-and-immune-response-breast-cancer-literature-review 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/current-challenges-management-nonsmall-cell-lung-cancer-brain-metastases 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/current-challenges-management-nonsmall-cell-lung-cancer-brain-metastases 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/current-challenges-management-nonsmall-cell-lung-cancer-brain-metastases 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/outcomes-based-age-phase-iii-meteor-trial-cabozantinib-versus-everolimus-patients-advanced-renal 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/outcomes-based-age-phase-iii-meteor-trial-cabozantinib-versus-everolimus-patients-advanced-renal 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/outcomes-based-age-phase-iii-meteor-trial-cabozantinib-versus-everolimus-patients-advanced-renal 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/role-postoperative-thoracic-radiotherapy-and-prophylactic-cranial-irradiation-early-stage-small 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/role-postoperative-thoracic-radiotherapy-and-prophylactic-cranial-irradiation-early-stage-small 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/role-postoperative-thoracic-radiotherapy-and-prophylactic-cranial-irradiation-early-stage-small 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/comprehensive-evaluation-methods-assess-overall-and-cell-specific-immune-infiltrates-breast-cancer 2024-03-31T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/comprehensive-evaluation-methods-assess-overall-and-cell-specific-immune-infiltrates-breast-cancer 2024-03-31T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/comprehensive-evaluation-methods-assess-overall-and-cell-specific-immune-infiltrates-breast-cancer 2024-03-31T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/sepsis-and-septic-shock-definitions-patients-cancer-admitted-icu 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/sepsis-and-septic-shock-definitions-patients-cancer-admitted-icu 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/sepsis-and-septic-shock-definitions-patients-cancer-admitted-icu 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/systemic-treatment-patients-early-breast-cancer-recent-updates-and-state-art 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/systemic-treatment-patients-early-breast-cancer-recent-updates-and-state-art 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/systemic-treatment-patients-early-breast-cancer-recent-updates-and-state-art 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/mechanisms-resistance-trastuzumab-emtansine-t-dm1-her2-positive-breast-cancer 2024-03-10T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/fr/mechanisms-resistance-trastuzumab-emtansine-t-dm1-her2-positive-breast-cancer 2024-03-10T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/nl/mechanisms-resistance-trastuzumab-emtansine-t-dm1-her2-positive-breast-cancer 2024-03-10T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/en/does-prediction-accuracy-osteoporotic-fractures-bmd-and-clinical-risk-factors-vary-fracture-site 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/does-prediction-accuracy-osteoporotic-fractures-bmd-and-clinical-risk-factors-vary-fracture-site 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/does-prediction-accuracy-osteoporotic-fractures-bmd-and-clinical-risk-factors-vary-fracture-site 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/rb-1-loss-function-gene-signature-tool-predict-response-neoadjuvant-chemotherapy-plus-anti-her2 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/rb-1-loss-function-gene-signature-tool-predict-response-neoadjuvant-chemotherapy-plus-anti-her2 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/rb-1-loss-function-gene-signature-tool-predict-response-neoadjuvant-chemotherapy-plus-anti-her2 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/continuous-professional-development-elevating-thoracic-oncology-education-europe 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/continuous-professional-development-elevating-thoracic-oncology-education-europe 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/continuous-professional-development-elevating-thoracic-oncology-education-europe 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/radiotherapy-treatment-extracranial-hemangiopericytomasolitary-fibrous-tumor-study-rare-cancer 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/radiotherapy-treatment-extracranial-hemangiopericytomasolitary-fibrous-tumor-study-rare-cancer 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/radiotherapy-treatment-extracranial-hemangiopericytomasolitary-fibrous-tumor-study-rare-cancer 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/impact-thyroid-disorders-clinical-pregnancy-outcomes-real-world-study-setting 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/impact-thyroid-disorders-clinical-pregnancy-outcomes-real-world-study-setting 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/impact-thyroid-disorders-clinical-pregnancy-outcomes-real-world-study-setting 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/cd36-mediated-metabolic-rewiring-breast-cancer-cells-promotes-resistance-her2-targeted-therapies 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/cd36-mediated-metabolic-rewiring-breast-cancer-cells-promotes-resistance-her2-targeted-therapies 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/cd36-mediated-metabolic-rewiring-breast-cancer-cells-promotes-resistance-her2-targeted-therapies 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/update-pathology-genetics-and-somatic-landscape-sebaceous-tumours 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/update-pathology-genetics-and-somatic-landscape-sebaceous-tumours 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/update-pathology-genetics-and-somatic-landscape-sebaceous-tumours 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/cdk46-inhibition-low-burden-and-extensive-metastatic-breast-cancer-summary-esmo-open-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/cdk46-inhibition-low-burden-and-extensive-metastatic-breast-cancer-summary-esmo-open-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/cdk46-inhibition-low-burden-and-extensive-metastatic-breast-cancer-summary-esmo-open-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/reference-values-eortc-qlq-c30-early-and-metastatic-breast-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/reference-values-eortc-qlq-c30-early-and-metastatic-breast-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/reference-values-eortc-qlq-c30-early-and-metastatic-breast-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/radical-approach-achieve-complete-cytoreductive-surgery-improve-survival-patients-advanced-ovarian 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/radical-approach-achieve-complete-cytoreductive-surgery-improve-survival-patients-advanced-ovarian 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/radical-approach-achieve-complete-cytoreductive-surgery-improve-survival-patients-advanced-ovarian 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/added-value-para-aortic-surgical-staging-compared-18f-fdg-petct-external-beam-radiation-field 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/added-value-para-aortic-surgical-staging-compared-18f-fdg-petct-external-beam-radiation-field 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/added-value-para-aortic-surgical-staging-compared-18f-fdg-petct-external-beam-radiation-field 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/oligometastatic-non-small-cell-lung-cancer-nsclc-does-number-metastasis-matter 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/oligometastatic-non-small-cell-lung-cancer-nsclc-does-number-metastasis-matter 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/oligometastatic-non-small-cell-lung-cancer-nsclc-does-number-metastasis-matter 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/analysis-inflammatory-markers-and-hormones-old-cancer-patients-descriptive-study 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/analysis-inflammatory-markers-and-hormones-old-cancer-patients-descriptive-study 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/analysis-inflammatory-markers-and-hormones-old-cancer-patients-descriptive-study 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/challenge-opiod-free-general-anesthesia-research 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/challenge-opiod-free-general-anesthesia-research 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/challenge-opiod-free-general-anesthesia-research 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/triple-negative-breast-cancer-microrna-expression-profile-and-novel-discriminators-according-brca1 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/triple-negative-breast-cancer-microrna-expression-profile-and-novel-discriminators-according-brca1 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/triple-negative-breast-cancer-microrna-expression-profile-and-novel-discriminators-according-brca1 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/intrathecal-catheter 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/intrathecal-catheter 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/intrathecal-catheter 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/new-therapeutic-targets-pancreatic-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/new-therapeutic-targets-pancreatic-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/new-therapeutic-targets-pancreatic-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/grey-areas-and-evidence-gaps-management-rectal-cancer-revealed-comparing-recommendations-clinical 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/grey-areas-and-evidence-gaps-management-rectal-cancer-revealed-comparing-recommendations-clinical 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/grey-areas-and-evidence-gaps-management-rectal-cancer-revealed-comparing-recommendations-clinical 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/use-low-level-laser-therapy-lllt-or-photobiomodulation-pbm-management-hand-foot-syndrome-hsf-or 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/use-low-level-laser-therapy-lllt-or-photobiomodulation-pbm-management-hand-foot-syndrome-hsf-or 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/use-low-level-laser-therapy-lllt-or-photobiomodulation-pbm-management-hand-foot-syndrome-hsf-or 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/early-prediction-neoadjuvant-treatment-outcome-locally-advanced-breast-cancer-using-parametric 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/early-prediction-neoadjuvant-treatment-outcome-locally-advanced-breast-cancer-using-parametric 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/early-prediction-neoadjuvant-treatment-outcome-locally-advanced-breast-cancer-using-parametric 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/metabolic-clinical-risk-score-new-prognostic-model-surgical-decision-making-patients-colorectal 2024-03-10T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/fr/metabolic-clinical-risk-score-new-prognostic-model-surgical-decision-making-patients-colorectal 2024-03-10T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/nl/metabolic-clinical-risk-score-new-prognostic-model-surgical-decision-making-patients-colorectal 2024-03-10T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/en/significance-tim3-expression-cancer-biology-clinic 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/significance-tim3-expression-cancer-biology-clinic 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/significance-tim3-expression-cancer-biology-clinic 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/dose-dense-adjuvant-chemotherapy-her2-positive-early-breast-cancer-patients-and-after-introduction 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/dose-dense-adjuvant-chemotherapy-her2-positive-early-breast-cancer-patients-and-after-introduction 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/dose-dense-adjuvant-chemotherapy-her2-positive-early-breast-cancer-patients-and-after-introduction 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/giant-desmoid-type-fibromatosis-neck-very-rare-infiltrating-tumor 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/giant-desmoid-type-fibromatosis-neck-very-rare-infiltrating-tumor 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/giant-desmoid-type-fibromatosis-neck-very-rare-infiltrating-tumor 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/advanced-stage-diagnosis-and-worse-clinicopathologic-features-young-women-breast-cancer-brazil 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/advanced-stage-diagnosis-and-worse-clinicopathologic-features-young-women-breast-cancer-brazil 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/advanced-stage-diagnosis-and-worse-clinicopathologic-features-young-women-breast-cancer-brazil 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/lenalidomide-maintenance-diffuse-large-b-cell-lymphoma-patients-responding-r-chop-quality-life 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/fr/lenalidomide-maintenance-diffuse-large-b-cell-lymphoma-patients-responding-r-chop-quality-life 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/nl/lenalidomide-maintenance-diffuse-large-b-cell-lymphoma-patients-responding-r-chop-quality-life 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/en/early-detection-metastatic-prostate-cancer-relapse-68ga-psma-11-petct-patient-still-exhibiting 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/early-detection-metastatic-prostate-cancer-relapse-68ga-psma-11-petct-patient-still-exhibiting 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/early-detection-metastatic-prostate-cancer-relapse-68ga-psma-11-petct-patient-still-exhibiting 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/ethical-climate-and-intention-leave-among-critical-care-clinicians-observational-study-68-intensive 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/ethical-climate-and-intention-leave-among-critical-care-clinicians-observational-study-68-intensive 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/ethical-climate-and-intention-leave-among-critical-care-clinicians-observational-study-68-intensive 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/pd-1-and-pd-l1-inhibitors-oesophago-gastric-cancers 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/pd-1-and-pd-l1-inhibitors-oesophago-gastric-cancers 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/pd-1-and-pd-l1-inhibitors-oesophago-gastric-cancers 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/sentinel-lymph-node-biopsy-high-risk-ductal-carcinoma-situ 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/sentinel-lymph-node-biopsy-high-risk-ductal-carcinoma-situ 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/sentinel-lymph-node-biopsy-high-risk-ductal-carcinoma-situ 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/unraveling-triple-negative-breast-cancer-tumor-microenvironment-heterogeneity-towards-optimized 2024-03-10T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/fr/unraveling-triple-negative-breast-cancer-tumor-microenvironment-heterogeneity-towards-optimized 2024-03-10T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/nl/unraveling-triple-negative-breast-cancer-tumor-microenvironment-heterogeneity-towards-optimized 2024-03-10T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/en/eortc-lung-cancer-group-survey-definition-nsclc-synchronous-oligometastatic-disease 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/eortc-lung-cancer-group-survey-definition-nsclc-synchronous-oligometastatic-disease 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/eortc-lung-cancer-group-survey-definition-nsclc-synchronous-oligometastatic-disease 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/post-mastectomy-radiation-therapy-human-epidermal-growth-factor-receptor-2-positive-breast-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/post-mastectomy-radiation-therapy-human-epidermal-growth-factor-receptor-2-positive-breast-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/post-mastectomy-radiation-therapy-human-epidermal-growth-factor-receptor-2-positive-breast-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/defining-oligometastatic-non-small-cell-lung-cancer-simulated-multidisciplinary-expert-opinion 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/defining-oligometastatic-non-small-cell-lung-cancer-simulated-multidisciplinary-expert-opinion 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/defining-oligometastatic-non-small-cell-lung-cancer-simulated-multidisciplinary-expert-opinion 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/radioembolization-90y-resin-microspheres-neuroendocrine-liver-metastases-after-initial-peptide 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/radioembolization-90y-resin-microspheres-neuroendocrine-liver-metastases-after-initial-peptide 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/radioembolization-90y-resin-microspheres-neuroendocrine-liver-metastases-after-initial-peptide 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/tumor-banks-quality-control-scheme-proposal 2024-04-14T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/tumor-banks-quality-control-scheme-proposal 2024-04-14T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/tumor-banks-quality-control-scheme-proposal 2024-04-14T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/extended-time-interval-between-diagnosis-and-surgery-does-not-improve-outcome-patients-operated 2024-03-10T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/fr/extended-time-interval-between-diagnosis-and-surgery-does-not-improve-outcome-patients-operated 2024-03-10T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/nl/extended-time-interval-between-diagnosis-and-surgery-does-not-improve-outcome-patients-operated 2024-03-10T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/en/hepatobiliary-complications-chronic-intestinal-failure 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/hepatobiliary-complications-chronic-intestinal-failure 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/hepatobiliary-complications-chronic-intestinal-failure 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/pooled-analysis-cardiac-events-trastuzumab-adjuvant-trials 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/pooled-analysis-cardiac-events-trastuzumab-adjuvant-trials 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/pooled-analysis-cardiac-events-trastuzumab-adjuvant-trials 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/novel-therapeutic-options-radioiodine-refractory-thyroid-cancer-redifferentiation-and-beyond 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/novel-therapeutic-options-radioiodine-refractory-thyroid-cancer-redifferentiation-and-beyond 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/novel-therapeutic-options-radioiodine-refractory-thyroid-cancer-redifferentiation-and-beyond 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/lucitanib-treatment-hrher2-metastatic-breast-cancer-results-multicohort-phase-ii-finesse-study 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/lucitanib-treatment-hrher2-metastatic-breast-cancer-results-multicohort-phase-ii-finesse-study 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/lucitanib-treatment-hrher2-metastatic-breast-cancer-results-multicohort-phase-ii-finesse-study 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/target-pharmacodynamic-activity-pi3k-inhibitor-copanlisib-paired-biopsies-patients-malignant 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/target-pharmacodynamic-activity-pi3k-inhibitor-copanlisib-paired-biopsies-patients-malignant 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/target-pharmacodynamic-activity-pi3k-inhibitor-copanlisib-paired-biopsies-patients-malignant 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/palbociclib-safety-and-efficacy-beyond-ribociclib-induced-liver-toxicity-metastatic-hormone 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/palbociclib-safety-and-efficacy-beyond-ribociclib-induced-liver-toxicity-metastatic-hormone 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/palbociclib-safety-and-efficacy-beyond-ribociclib-induced-liver-toxicity-metastatic-hormone 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/comparison-mismatch-repair-deficiency-colorectal-cancers-between-african-and-european-cohorts 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/comparison-mismatch-repair-deficiency-colorectal-cancers-between-african-and-european-cohorts 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/comparison-mismatch-repair-deficiency-colorectal-cancers-between-african-and-european-cohorts 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/systematic-review-and-meta-analysis-comparing-outcomes-open-and-robotic-assisted-radical-cystectomy 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/systematic-review-and-meta-analysis-comparing-outcomes-open-and-robotic-assisted-radical-cystectomy 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/systematic-review-and-meta-analysis-comparing-outcomes-open-and-robotic-assisted-radical-cystectomy 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/human-hepatocytes-and-differentiated-adult-derived-human-liver-stemprogenitor-cells-display-vitro 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/human-hepatocytes-and-differentiated-adult-derived-human-liver-stemprogenitor-cells-display-vitro 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/human-hepatocytes-and-differentiated-adult-derived-human-liver-stemprogenitor-cells-display-vitro 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/long-term-outcomes-neoadjuvant-versus-adjuvant-chemotherapy-early-breast-cancer-meta-analysis 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/long-term-outcomes-neoadjuvant-versus-adjuvant-chemotherapy-early-breast-cancer-meta-analysis 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/long-term-outcomes-neoadjuvant-versus-adjuvant-chemotherapy-early-breast-cancer-meta-analysis 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/clinical-outcome-and-toxicity-after-simultaneous-integrated-boost-imrt-head-and-neck-squamous-cell 2024-05-05T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/clinical-outcome-and-toxicity-after-simultaneous-integrated-boost-imrt-head-and-neck-squamous-cell 2024-05-05T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/clinical-outcome-and-toxicity-after-simultaneous-integrated-boost-imrt-head-and-neck-squamous-cell 2024-05-05T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/evaluation-psma-expression-changes-petct-and-after-initiation-novel-antiandrogen-drugs-enzalutamide 2024-03-10T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/fr/evaluation-psma-expression-changes-petct-and-after-initiation-novel-antiandrogen-drugs-enzalutamide 2024-03-10T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/nl/evaluation-psma-expression-changes-petct-and-after-initiation-novel-antiandrogen-drugs-enzalutamide 2024-03-10T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/en/prognostic-impact-glioblastoma-stem-cell-markers-olig2-and-ccnd2 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/prognostic-impact-glioblastoma-stem-cell-markers-olig2-and-ccnd2 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/prognostic-impact-glioblastoma-stem-cell-markers-olig2-and-ccnd2 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/scintigraphic-investigations-deep-and-superficial-lymphatic-systems-evaluation-lower-limb-oedema 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/scintigraphic-investigations-deep-and-superficial-lymphatic-systems-evaluation-lower-limb-oedema 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/scintigraphic-investigations-deep-and-superficial-lymphatic-systems-evaluation-lower-limb-oedema 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/modalities-mobilization-and-hematopoietic-stem-cells-objectives-autologous-transplantation 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/fr/modalities-mobilization-and-hematopoietic-stem-cells-objectives-autologous-transplantation 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/nl/modalities-mobilization-and-hematopoietic-stem-cells-objectives-autologous-transplantation 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/en/direct-admission-intensive-care-unit-emergency-department-and-mortality-critically-ill-hematology 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/direct-admission-intensive-care-unit-emergency-department-and-mortality-critically-ill-hematology 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/direct-admission-intensive-care-unit-emergency-department-and-mortality-critically-ill-hematology 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/biological-response-mesenchymal-stromal-cells-thymol-and-carvacrol-comparison-their-essential-oil 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/biological-response-mesenchymal-stromal-cells-thymol-and-carvacrol-comparison-their-essential-oil 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/biological-response-mesenchymal-stromal-cells-thymol-and-carvacrol-comparison-their-essential-oil 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/tumor-derived-thymic-stromal-lymphopoietin-expands-bone-marrow-b-cell-precursors-circulation 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/tumor-derived-thymic-stromal-lymphopoietin-expands-bone-marrow-b-cell-precursors-circulation 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/tumor-derived-thymic-stromal-lymphopoietin-expands-bone-marrow-b-cell-precursors-circulation 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/folfiri-second-line-treatment-metastatic-biliary-tract-cancer-patients 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/folfiri-second-line-treatment-metastatic-biliary-tract-cancer-patients 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/folfiri-second-line-treatment-metastatic-biliary-tract-cancer-patients 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/clinical-applications-donor-lymphocyte-infusion-hla-haploidentical-donor-consensus-recommendations 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/clinical-applications-donor-lymphocyte-infusion-hla-haploidentical-donor-consensus-recommendations 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/clinical-applications-donor-lymphocyte-infusion-hla-haploidentical-donor-consensus-recommendations 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/fifteen-year-history-european-head-and-neck-society 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/fifteen-year-history-european-head-and-neck-society 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/fifteen-year-history-european-head-and-neck-society 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/current-management-limited-stage-sclc-and-convert-trial-impact-results-eortc-lung-cancer-group 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/current-management-limited-stage-sclc-and-convert-trial-impact-results-eortc-lung-cancer-group 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/current-management-limited-stage-sclc-and-convert-trial-impact-results-eortc-lung-cancer-group 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/lung-transplantation-lepidic-invasive-adenocarcinoma-clinical-question-ethical-consideration 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/lung-transplantation-lepidic-invasive-adenocarcinoma-clinical-question-ethical-consideration 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/lung-transplantation-lepidic-invasive-adenocarcinoma-clinical-question-ethical-consideration 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/retrospective-evaluation-safety-low-level-laser-therapyphotobiomodulation-patients-headneck-cancer 2024-05-05T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/retrospective-evaluation-safety-low-level-laser-therapyphotobiomodulation-patients-headneck-cancer 2024-05-05T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/retrospective-evaluation-safety-low-level-laser-therapyphotobiomodulation-patients-headneck-cancer 2024-05-05T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/impact-hpv-infection-immune-system-oropharyngeal-and-non-oropharyngeal-squamous-cell-carcinoma 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/impact-hpv-infection-immune-system-oropharyngeal-and-non-oropharyngeal-squamous-cell-carcinoma 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/impact-hpv-infection-immune-system-oropharyngeal-and-non-oropharyngeal-squamous-cell-carcinoma 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/persistent-anti-tumor-response-cancer-patients-experiencing-pneumonitis-related-immune-checkpoint 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/persistent-anti-tumor-response-cancer-patients-experiencing-pneumonitis-related-immune-checkpoint 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/persistent-anti-tumor-response-cancer-patients-experiencing-pneumonitis-related-immune-checkpoint 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/personalized-medicine-genomic-profiling-and-germline-mutations-toward-more-precise-decisions 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/personalized-medicine-genomic-profiling-and-germline-mutations-toward-more-precise-decisions 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/personalized-medicine-genomic-profiling-and-germline-mutations-toward-more-precise-decisions 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/rare-presentation-small-diaphragmatic-epidermoid-cyst-extremely-elevated-serum-ca19-9-level 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/rare-presentation-small-diaphragmatic-epidermoid-cyst-extremely-elevated-serum-ca19-9-level 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/rare-presentation-small-diaphragmatic-epidermoid-cyst-extremely-elevated-serum-ca19-9-level 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/safety-and-efficacy-nivolumab-monotherapy-recurrent-or-metastatic-cervical-vaginal-or-vulvar 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/safety-and-efficacy-nivolumab-monotherapy-recurrent-or-metastatic-cervical-vaginal-or-vulvar 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/safety-and-efficacy-nivolumab-monotherapy-recurrent-or-metastatic-cervical-vaginal-or-vulvar 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/phase-ii-randomised-discontinuation-trial-brivanib-patients-advanced-solid-tumours 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/phase-ii-randomised-discontinuation-trial-brivanib-patients-advanced-solid-tumours 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/phase-ii-randomised-discontinuation-trial-brivanib-patients-advanced-solid-tumours 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/emerald-phase-iii-trial-elacestrant-rad1901-vs-endocrine-therapy-previously-treated-er-advanced 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/emerald-phase-iii-trial-elacestrant-rad1901-vs-endocrine-therapy-previously-treated-er-advanced 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/emerald-phase-iii-trial-elacestrant-rad1901-vs-endocrine-therapy-previously-treated-er-advanced 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/salvage-hemiablation-high-intensity-focused-ultrasound-unilateral-radio-recurrent-prostate-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/salvage-hemiablation-high-intensity-focused-ultrasound-unilateral-radio-recurrent-prostate-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/salvage-hemiablation-high-intensity-focused-ultrasound-unilateral-radio-recurrent-prostate-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/tumor-infiltrating-b-cells-signal-functional-humoral-immune-responses-breast-cancer 2024-03-31T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/tumor-infiltrating-b-cells-signal-functional-humoral-immune-responses-breast-cancer 2024-03-31T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/tumor-infiltrating-b-cells-signal-functional-humoral-immune-responses-breast-cancer 2024-03-31T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/lag3-biological-processes-motivate-targeting-immune-checkpoint-molecule-human-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/lag3-biological-processes-motivate-targeting-immune-checkpoint-molecule-human-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/lag3-biological-processes-motivate-targeting-immune-checkpoint-molecule-human-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/secondary-technical-resectability-colorectal-cancer-liver-metastases-after-chemotherapy-or-without 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/secondary-technical-resectability-colorectal-cancer-liver-metastases-after-chemotherapy-or-without 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/secondary-technical-resectability-colorectal-cancer-liver-metastases-after-chemotherapy-or-without 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/neoadjuvant-letrozole-plus-taselisib-versus-letrozole-plus-placebo-postmenopausal-women-oestrogen 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/neoadjuvant-letrozole-plus-taselisib-versus-letrozole-plus-placebo-postmenopausal-women-oestrogen 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/neoadjuvant-letrozole-plus-taselisib-versus-letrozole-plus-placebo-postmenopausal-women-oestrogen 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/simplified-frailty-scale-predicts-outcomes-transplant-ineligible-patients-newly-diagnosed-multiple 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/fr/simplified-frailty-scale-predicts-outcomes-transplant-ineligible-patients-newly-diagnosed-multiple 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/nl/simplified-frailty-scale-predicts-outcomes-transplant-ineligible-patients-newly-diagnosed-multiple 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/en/clinical-significance-dna-methylation-chronic-lymphocytic-leukemia-patients-results-3-uk-clinical 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/clinical-significance-dna-methylation-chronic-lymphocytic-leukemia-patients-results-3-uk-clinical 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/clinical-significance-dna-methylation-chronic-lymphocytic-leukemia-patients-results-3-uk-clinical 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/definition-synchronous-oligometastatic-non-small-cell-lung-cancer-consensus-report 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/definition-synchronous-oligometastatic-non-small-cell-lung-cancer-consensus-report 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/definition-synchronous-oligometastatic-non-small-cell-lung-cancer-consensus-report 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/adenosine-a2a-receptor-promotes-lymphangiogenesis-and-lymph-node-metastasis 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/adenosine-a2a-receptor-promotes-lymphangiogenesis-and-lymph-node-metastasis 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/adenosine-a2a-receptor-promotes-lymphangiogenesis-and-lymph-node-metastasis 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/pet-and-mri-based-rt-treatment-planning-handling-uncertainties 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/pet-and-mri-based-rt-treatment-planning-handling-uncertainties 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/pet-and-mri-based-rt-treatment-planning-handling-uncertainties 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/oral-selinexor-dexamethasone-triple-class-refractory-multiple-myeloma 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/fr/oral-selinexor-dexamethasone-triple-class-refractory-multiple-myeloma 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/nl/oral-selinexor-dexamethasone-triple-class-refractory-multiple-myeloma 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/en/allogeneic-stem-cell-transplantation-acquired-pure-red-cell-aplasia 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/fr/allogeneic-stem-cell-transplantation-acquired-pure-red-cell-aplasia 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/nl/allogeneic-stem-cell-transplantation-acquired-pure-red-cell-aplasia 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/en/testicular-microlithiasis-systematic-review-and-clinical-guidelines 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/testicular-microlithiasis-systematic-review-and-clinical-guidelines 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/testicular-microlithiasis-systematic-review-and-clinical-guidelines 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/immunogenicity-and-safety-adjuvanted-recombinant-zoster-vaccine-adults-haematological-malignancies 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/immunogenicity-and-safety-adjuvanted-recombinant-zoster-vaccine-adults-haematological-malignancies 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/immunogenicity-and-safety-adjuvanted-recombinant-zoster-vaccine-adults-haematological-malignancies 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/benefit-reactivating-p53-under-mapk-inhibition-efficacy-radiotherapy-melanoma 2024-04-14T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/benefit-reactivating-p53-under-mapk-inhibition-efficacy-radiotherapy-melanoma 2024-04-14T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/benefit-reactivating-p53-under-mapk-inhibition-efficacy-radiotherapy-melanoma 2024-04-14T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/personalised-radioembolization-improves-outcomes-refractory-intra-hepatic-cholangiocarcinoma 2024-05-05T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/personalised-radioembolization-improves-outcomes-refractory-intra-hepatic-cholangiocarcinoma 2024-05-05T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/personalised-radioembolization-improves-outcomes-refractory-intra-hepatic-cholangiocarcinoma 2024-05-05T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/essential-role-human-t-cell-leukemia-virus-type-1-orf-i-lethal-proliferation-cd4-cells-humanized 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/essential-role-human-t-cell-leukemia-virus-type-1-orf-i-lethal-proliferation-cd4-cells-humanized 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/essential-role-human-t-cell-leukemia-virus-type-1-orf-i-lethal-proliferation-cd4-cells-humanized 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/survival-outcomes-neoaltto-study-big-1-06-updated-results-randomised-multicenter-phase-iii 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/survival-outcomes-neoaltto-study-big-1-06-updated-results-randomised-multicenter-phase-iii 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/survival-outcomes-neoaltto-study-big-1-06-updated-results-randomised-multicenter-phase-iii 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/chimeric-antigen-receptor-t-cells-targeting-solid-tumors-current-challenges-and-existing-strategies 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/chimeric-antigen-receptor-t-cells-targeting-solid-tumors-current-challenges-and-existing-strategies 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/chimeric-antigen-receptor-t-cells-targeting-solid-tumors-current-challenges-and-existing-strategies 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/selective-oestrogen-receptor-degraders-breast-cancer-review-and-perspectives 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/selective-oestrogen-receptor-degraders-breast-cancer-review-and-perspectives 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/selective-oestrogen-receptor-degraders-breast-cancer-review-and-perspectives 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/early-post-treatment-prostate-specific-antigen-4-weeks-and-abiraterone-and-enzalutamide-treatment 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/early-post-treatment-prostate-specific-antigen-4-weeks-and-abiraterone-and-enzalutamide-treatment 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/early-post-treatment-prostate-specific-antigen-4-weeks-and-abiraterone-and-enzalutamide-treatment 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/how-assimilate-tsunami-immune-checkpoints-inhibitors-data-clinical-practice 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/how-assimilate-tsunami-immune-checkpoints-inhibitors-data-clinical-practice 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/how-assimilate-tsunami-immune-checkpoints-inhibitors-data-clinical-practice 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/first-case-campylobacter-rectus-and-solobacterium-moorei-mixed-bacteraemia-successfully-identified 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/first-case-campylobacter-rectus-and-solobacterium-moorei-mixed-bacteraemia-successfully-identified 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/first-case-campylobacter-rectus-and-solobacterium-moorei-mixed-bacteraemia-successfully-identified 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/checkpoints-inhibitors-neoadjuvant-setting-solid-tumors-lessons-learnt-and-perspectives 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/checkpoints-inhibitors-neoadjuvant-setting-solid-tumors-lessons-learnt-and-perspectives 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/checkpoints-inhibitors-neoadjuvant-setting-solid-tumors-lessons-learnt-and-perspectives 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/persephone-implications-clinical-practice-2019 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/persephone-implications-clinical-practice-2019 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/persephone-implications-clinical-practice-2019 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/targeting-pd-1-cancer-biological-insights-focus-breast-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/targeting-pd-1-cancer-biological-insights-focus-breast-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/targeting-pd-1-cancer-biological-insights-focus-breast-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/tandem-autologous-stem-cell-transplantation-improves-outcomes-newly-diagnosed-multiple-myeloma 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/fr/tandem-autologous-stem-cell-transplantation-improves-outcomes-newly-diagnosed-multiple-myeloma 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/nl/tandem-autologous-stem-cell-transplantation-improves-outcomes-newly-diagnosed-multiple-myeloma 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/en/nbtxr3-first-class-radioenhancer-hafnium-oxide-nanoparticle-plus-radiotherapy-versus-radiotherapy 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/nbtxr3-first-class-radioenhancer-hafnium-oxide-nanoparticle-plus-radiotherapy-versus-radiotherapy 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/nbtxr3-first-class-radioenhancer-hafnium-oxide-nanoparticle-plus-radiotherapy-versus-radiotherapy 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/conservative-surgical-treatment-borderline-ovarian-brenner-tumour-pre-menopausal-woman-subsequent 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/conservative-surgical-treatment-borderline-ovarian-brenner-tumour-pre-menopausal-woman-subsequent 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/conservative-surgical-treatment-borderline-ovarian-brenner-tumour-pre-menopausal-woman-subsequent 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/41-gene-classifier-trar-predicts-response-her2-positive-breast-cancer-patients-neoaltto-study 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/41-gene-classifier-trar-predicts-response-her2-positive-breast-cancer-patients-neoaltto-study 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/41-gene-classifier-trar-predicts-response-her2-positive-breast-cancer-patients-neoaltto-study 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/randomized-phase-iii-study-admyre-plitidepsin-combination-dexamethasone-vs-dexamethasone-alone 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/fr/randomized-phase-iii-study-admyre-plitidepsin-combination-dexamethasone-vs-dexamethasone-alone 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/nl/randomized-phase-iii-study-admyre-plitidepsin-combination-dexamethasone-vs-dexamethasone-alone 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/en/immune-evasion-tumour-invasion-early-lung-squamous-carcinogenesis 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/fr/immune-evasion-tumour-invasion-early-lung-squamous-carcinogenesis 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/nl/immune-evasion-tumour-invasion-early-lung-squamous-carcinogenesis 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/en/her2-targeted-treatment-older-patients-breast-cancer-expert-position-paper-international-society 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/her2-targeted-treatment-older-patients-breast-cancer-expert-position-paper-international-society 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/her2-targeted-treatment-older-patients-breast-cancer-expert-position-paper-international-society 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/current-controversies-and-future-perspectives-treatment-intensive-care-unit-delirium-adults 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/current-controversies-and-future-perspectives-treatment-intensive-care-unit-delirium-adults 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/current-controversies-and-future-perspectives-treatment-intensive-care-unit-delirium-adults 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/are-we-assuming-too-much-our-statistical-assumptions-lessons-learned-altto-trial 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/are-we-assuming-too-much-our-statistical-assumptions-lessons-learned-altto-trial 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/are-we-assuming-too-much-our-statistical-assumptions-lessons-learned-altto-trial 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/trastuzumab-duocarmazine-locally-advanced-and-metastatic-solid-tumours-and-her2-expressing-breast 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/trastuzumab-duocarmazine-locally-advanced-and-metastatic-solid-tumours-and-her2-expressing-breast 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/trastuzumab-duocarmazine-locally-advanced-and-metastatic-solid-tumours-and-her2-expressing-breast 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/microrna-profiling-and-identification-let-7a-target-prevent-chemotherapy-induced-primordial 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/microrna-profiling-and-identification-let-7a-target-prevent-chemotherapy-induced-primordial 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/microrna-profiling-and-identification-let-7a-target-prevent-chemotherapy-induced-primordial 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/low-68ga-psma-petct-uptake-chronic-intramuscular-nodular-fasciitis 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/low-68ga-psma-petct-uptake-chronic-intramuscular-nodular-fasciitis 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/low-68ga-psma-petct-uptake-chronic-intramuscular-nodular-fasciitis 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/incidental-detection-radiation-induced-soft-tissue-sarcoma-68ga-psma-petct-patient-previously 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/incidental-detection-radiation-induced-soft-tissue-sarcoma-68ga-psma-petct-patient-previously 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/incidental-detection-radiation-induced-soft-tissue-sarcoma-68ga-psma-petct-patient-previously 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/marginal-zone-lymphomas-second-most-common-lymphomas-older-patients 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/fr/marginal-zone-lymphomas-second-most-common-lymphomas-older-patients 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/nl/marginal-zone-lymphomas-second-most-common-lymphomas-older-patients 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/en/therapeutic-management-malignant-paragangliomas-illustrative-case-and-literature-review 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/therapeutic-management-malignant-paragangliomas-illustrative-case-and-literature-review 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/therapeutic-management-malignant-paragangliomas-illustrative-case-and-literature-review 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/investigational-drugs-early-stage-clinical-trials-treatment-her2-breast-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/investigational-drugs-early-stage-clinical-trials-treatment-her2-breast-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/investigational-drugs-early-stage-clinical-trials-treatment-her2-breast-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/prognostic-implications-pd-l1-expression-breast-cancer-systematic-review-and-meta-analysis 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/prognostic-implications-pd-l1-expression-breast-cancer-systematic-review-and-meta-analysis 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/prognostic-implications-pd-l1-expression-breast-cancer-systematic-review-and-meta-analysis 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/neoadjuvant-treatment-intermediatehigh-risk-her2-positive-and-triple-negative-breast-cancers-no 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/neoadjuvant-treatment-intermediatehigh-risk-her2-positive-and-triple-negative-breast-cancers-no 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/neoadjuvant-treatment-intermediatehigh-risk-her2-positive-and-triple-negative-breast-cancers-no 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/how-i-treat-metastatic-triple-negative-breast-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/how-i-treat-metastatic-triple-negative-breast-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/how-i-treat-metastatic-triple-negative-breast-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/surgical-safety-cytoreductive-nephrectomy-following-sunitinib-results-multicentre-randomised 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/surgical-safety-cytoreductive-nephrectomy-following-sunitinib-results-multicentre-randomised 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/surgical-safety-cytoreductive-nephrectomy-following-sunitinib-results-multicentre-randomised 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/relationship-between-tumor-infiltrating-lymphocytes-pd-l1-expression-driver-mutations-and-clinical 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/relationship-between-tumor-infiltrating-lymphocytes-pd-l1-expression-driver-mutations-and-clinical 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/relationship-between-tumor-infiltrating-lymphocytes-pd-l1-expression-driver-mutations-and-clinical 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/seterpr-robust-18-gene-predictor-sensitivity-endocrine-therapy-metastatic-breast-cancer 2024-03-10T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/fr/seterpr-robust-18-gene-predictor-sensitivity-endocrine-therapy-metastatic-breast-cancer 2024-03-10T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/nl/seterpr-robust-18-gene-predictor-sensitivity-endocrine-therapy-metastatic-breast-cancer 2024-03-10T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/en/burden-low-anterior-resection-syndrome-quality-life-patients-mid-or-low-rectal-cancer 2024-05-05T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/burden-low-anterior-resection-syndrome-quality-life-patients-mid-or-low-rectal-cancer 2024-05-05T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/burden-low-anterior-resection-syndrome-quality-life-patients-mid-or-low-rectal-cancer 2024-05-05T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/impact-neutrophil-lymphocyte-platelet-lymphocyte-and-haemoglobin-platelet-ratio-localised-renal 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/impact-neutrophil-lymphocyte-platelet-lymphocyte-and-haemoglobin-platelet-ratio-localised-renal 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/impact-neutrophil-lymphocyte-platelet-lymphocyte-and-haemoglobin-platelet-ratio-localised-renal 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/defining-synchronous-oligometastatic-non-small-cell-lung-cancer-systematic-review 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/defining-synchronous-oligometastatic-non-small-cell-lung-cancer-systematic-review 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/defining-synchronous-oligometastatic-non-small-cell-lung-cancer-systematic-review 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/les-patients-ages-de-plus-de-65-ans-atteints-d-un-cancer-admis-aux-soins-intensifs 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/les-patients-ages-de-plus-de-65-ans-atteints-d-un-cancer-admis-aux-soins-intensifs 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/les-patients-ages-de-plus-de-65-ans-atteints-d-un-cancer-admis-aux-soins-intensifs 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/reduction-d-un-traitement-chronique-par-inhibiteur-de-la-pompe-protons-possible 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/reduction-d-un-traitement-chronique-par-inhibiteur-de-la-pompe-protons-possible 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/reduction-d-un-traitement-chronique-par-inhibiteur-de-la-pompe-protons-possible 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/arguments-supplementaires-pour-espacer-le-depistage-du-cancer-du-col-uterin-en-cas-de-recherche 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/arguments-supplementaires-pour-espacer-le-depistage-du-cancer-du-col-uterin-en-cas-de-recherche 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/arguments-supplementaires-pour-espacer-le-depistage-du-cancer-du-col-uterin-en-cas-de-recherche 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/algorithme-years-pour-eviter-sans-risque-majore-l-angio-tdm-dans-le-diagnostic-initial-de-l-embolie 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/algorithme-years-pour-eviter-sans-risque-majore-l-angio-tdm-dans-le-diagnostic-initial-de-l-embolie 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/algorithme-years-pour-eviter-sans-risque-majore-l-angio-tdm-dans-le-diagnostic-initial-de-l-embolie 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/prostatectomie-ou-surveillance-active-pour-un-cancer-localise-de-la-prostate-faible-risque-analyses 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/prostatectomie-ou-surveillance-active-pour-un-cancer-localise-de-la-prostate-faible-risque-analyses 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/prostatectomie-ou-surveillance-active-pour-un-cancer-localise-de-la-prostate-faible-risque-analyses 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/thromboprophylaxie-prolongee-suite-un-alitement-pour-raison-medicale-analyses-breves 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/thromboprophylaxie-prolongee-suite-un-alitement-pour-raison-medicale-analyses-breves 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/thromboprophylaxie-prolongee-suite-un-alitement-pour-raison-medicale-analyses-breves 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/chimiotherapie-apres-traitement-curatif-d-un-cancer-colorectal-analyses-breves 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/chimiotherapie-apres-traitement-curatif-d-un-cancer-colorectal-analyses-breves 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/chimiotherapie-apres-traitement-curatif-d-un-cancer-colorectal-analyses-breves 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/risque-de-cancers-mammaires-et-ovariens-chez-les-femmes-porteuses-de-mutations-brca1-et-brca2 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/risque-de-cancers-mammaires-et-ovariens-chez-les-femmes-porteuses-de-mutations-brca1-et-brca2 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/risque-de-cancers-mammaires-et-ovariens-chez-les-femmes-porteuses-de-mutations-brca1-et-brca2 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/multicultural-approaches-cancer-pain 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/multicultural-approaches-cancer-pain 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/multicultural-approaches-cancer-pain 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/iniparib-administered-weekly-or-twice-weekly-combination-gemcitabinecarboplatin-patients-metastatic 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/iniparib-administered-weekly-or-twice-weekly-combination-gemcitabinecarboplatin-patients-metastatic 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/iniparib-administered-weekly-or-twice-weekly-combination-gemcitabinecarboplatin-patients-metastatic 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/targeted-therapy-breast-cancer-older-patients 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/targeted-therapy-breast-cancer-older-patients 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/targeted-therapy-breast-cancer-older-patients 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/bortezomib-thalidomide-and-dexamethasone-or-without-daratumumab-and-after-autologous-stem-cell 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/fr/bortezomib-thalidomide-and-dexamethasone-or-without-daratumumab-and-after-autologous-stem-cell 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/nl/bortezomib-thalidomide-and-dexamethasone-or-without-daratumumab-and-after-autologous-stem-cell 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/en/brain-metastasis-and-renal-cell-carcinoma-prognostic-scores-assessment-era-targeted-therapies 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/brain-metastasis-and-renal-cell-carcinoma-prognostic-scores-assessment-era-targeted-therapies 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/brain-metastasis-and-renal-cell-carcinoma-prognostic-scores-assessment-era-targeted-therapies 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/bullous-lupus-under-nivolumab-treatment-lung-cancer-case-report-systematic-literature-review 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/bullous-lupus-under-nivolumab-treatment-lung-cancer-case-report-systematic-literature-review 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/bullous-lupus-under-nivolumab-treatment-lung-cancer-case-report-systematic-literature-review 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/interruption-or-discontinuation-tyrosine-kinase-inhibitor-treatment-chronic-myeloid-leukaemia 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/interruption-or-discontinuation-tyrosine-kinase-inhibitor-treatment-chronic-myeloid-leukaemia 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/interruption-or-discontinuation-tyrosine-kinase-inhibitor-treatment-chronic-myeloid-leukaemia 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/68ga-psma-11-petct-patient-non-psa-secreting-undifferentiated-prostate-cancer-and-after-treatment 2024-03-10T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/fr/68ga-psma-11-petct-patient-non-psa-secreting-undifferentiated-prostate-cancer-and-after-treatment 2024-03-10T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/nl/68ga-psma-11-petct-patient-non-psa-secreting-undifferentiated-prostate-cancer-and-after-treatment 2024-03-10T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/en/orthostatic-blood-pressure-drop-and-cardiovascular-and-psychotropic-medication-dosages-acutely-ill 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/orthostatic-blood-pressure-drop-and-cardiovascular-and-psychotropic-medication-dosages-acutely-ill 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/orthostatic-blood-pressure-drop-and-cardiovascular-and-psychotropic-medication-dosages-acutely-ill 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/different-shades-pancreatic-ductal-adenocarcinoma-different-paths-towards-precision-therapeutic 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/different-shades-pancreatic-ductal-adenocarcinoma-different-paths-towards-precision-therapeutic 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/different-shades-pancreatic-ductal-adenocarcinoma-different-paths-towards-precision-therapeutic 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/dissecting-effect-hormone-receptor-status-patients-her2-positive-early-breast-cancer-exploratory 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/dissecting-effect-hormone-receptor-status-patients-her2-positive-early-breast-cancer-exploratory 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/dissecting-effect-hormone-receptor-status-patients-her2-positive-early-breast-cancer-exploratory 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/primmo-study-protocol-phase-ii-study-combining-pd-1-blockade-radiation-and-immunomodulation-tackle 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/primmo-study-protocol-phase-ii-study-combining-pd-1-blockade-radiation-and-immunomodulation-tackle 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/primmo-study-protocol-phase-ii-study-combining-pd-1-blockade-radiation-and-immunomodulation-tackle 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/radiotherapy-treatment-planning-prostate-cancer-using-magnetic-resonance-imaging 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/radiotherapy-treatment-planning-prostate-cancer-using-magnetic-resonance-imaging 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/radiotherapy-treatment-planning-prostate-cancer-using-magnetic-resonance-imaging 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/elastic-fusion-biopsy-versus-systematic-biopsy-prostate-cancer-detection-results-multicentric-study 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/elastic-fusion-biopsy-versus-systematic-biopsy-prostate-cancer-detection-results-multicentric-study 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/elastic-fusion-biopsy-versus-systematic-biopsy-prostate-cancer-detection-results-multicentric-study 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/validated-prospective-assessment-quality-life-after-robot-assisted-laparoscopic-prostatectomy 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/validated-prospective-assessment-quality-life-after-robot-assisted-laparoscopic-prostatectomy 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/validated-prospective-assessment-quality-life-after-robot-assisted-laparoscopic-prostatectomy 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/identification-three-subtypes-triple-negative-breast-cancer-potential-therapeutic-implications 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/identification-three-subtypes-triple-negative-breast-cancer-potential-therapeutic-implications 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/identification-three-subtypes-triple-negative-breast-cancer-potential-therapeutic-implications 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/long-term-follow-trial-comparing-post-remission-treatment-autologous-or-allogeneic-bone-marrow 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/fr/long-term-follow-trial-comparing-post-remission-treatment-autologous-or-allogeneic-bone-marrow 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/nl/long-term-follow-trial-comparing-post-remission-treatment-autologous-or-allogeneic-bone-marrow 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/en/alpk1-hotspot-mutation-driver-human-spiradenoma-and-spiradenocarcinoma 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/alpk1-hotspot-mutation-driver-human-spiradenoma-and-spiradenocarcinoma 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/alpk1-hotspot-mutation-driver-human-spiradenoma-and-spiradenocarcinoma 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/promises-and-pitfalls-using-liquid-biopsy-precision-medicine 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/promises-and-pitfalls-using-liquid-biopsy-precision-medicine 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/promises-and-pitfalls-using-liquid-biopsy-precision-medicine 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/diagnosis-and-outcome-acute-respiratory-failure-immunocompromised-patients-after-bronchoscopy 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/diagnosis-and-outcome-acute-respiratory-failure-immunocompromised-patients-after-bronchoscopy 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/diagnosis-and-outcome-acute-respiratory-failure-immunocompromised-patients-after-bronchoscopy 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/carfilzomib-weekly-plus-melphalan-and-prednisone-newly-diagnosed-transplant-ineligible-multiple 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/fr/carfilzomib-weekly-plus-melphalan-and-prednisone-newly-diagnosed-transplant-ineligible-multiple 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/nl/carfilzomib-weekly-plus-melphalan-and-prednisone-newly-diagnosed-transplant-ineligible-multiple 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/en/adjuvant-therapeutic-approaches-her2-positive-breast-cancer-focus-neratinib-maleate 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/adjuvant-therapeutic-approaches-her2-positive-breast-cancer-focus-neratinib-maleate 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/adjuvant-therapeutic-approaches-her2-positive-breast-cancer-focus-neratinib-maleate 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/prevention-monitoring-and-management-cardiac-dysfunction-patients-metastatic-breast-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/prevention-monitoring-and-management-cardiac-dysfunction-patients-metastatic-breast-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/prevention-monitoring-and-management-cardiac-dysfunction-patients-metastatic-breast-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/prognostic-role-serum-thymidine-kinase-1-activity-patients-hormone-receptor-positive-metastatic 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/prognostic-role-serum-thymidine-kinase-1-activity-patients-hormone-receptor-positive-metastatic 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/prognostic-role-serum-thymidine-kinase-1-activity-patients-hormone-receptor-positive-metastatic 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/heterogeneity-68ga-psma-petct-uptake-fibrous-dysplasia 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/heterogeneity-68ga-psma-petct-uptake-fibrous-dysplasia 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/heterogeneity-68ga-psma-petct-uptake-fibrous-dysplasia 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/adjuvant-therapy-options-renal-cell-carcinoma-where-do-we-stand 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/adjuvant-therapy-options-renal-cell-carcinoma-where-do-we-stand 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/adjuvant-therapy-options-renal-cell-carcinoma-where-do-we-stand 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/promising-immuno-oncology-treatments-beyond-2018-nobel-prize 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/promising-immuno-oncology-treatments-beyond-2018-nobel-prize 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/promising-immuno-oncology-treatments-beyond-2018-nobel-prize 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/denosumab-early-stage-breast-cancer 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/denosumab-early-stage-breast-cancer 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/denosumab-early-stage-breast-cancer 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/close-interrelation-between-colorectal-cancer-infection-and-microbiota 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/close-interrelation-between-colorectal-cancer-infection-and-microbiota 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/close-interrelation-between-colorectal-cancer-infection-and-microbiota 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/recent-advances-understanding-breast-cancer-and-emerging-therapies-focus-luminal-and-triple 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/recent-advances-understanding-breast-cancer-and-emerging-therapies-focus-luminal-and-triple 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/recent-advances-understanding-breast-cancer-and-emerging-therapies-focus-luminal-and-triple 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/weekly-carboplatin-plus-neoadjuvant-anthracycline-taxane-based-regimen-early-triple-negative-breast 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/weekly-carboplatin-plus-neoadjuvant-anthracycline-taxane-based-regimen-early-triple-negative-breast 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/weekly-carboplatin-plus-neoadjuvant-anthracycline-taxane-based-regimen-early-triple-negative-breast 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/simultaneous-transanal-endolaparoscopic-resection-large-anal-canal-and-low-rectal-polyps-video 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/simultaneous-transanal-endolaparoscopic-resection-large-anal-canal-and-low-rectal-polyps-video 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/simultaneous-transanal-endolaparoscopic-resection-large-anal-canal-and-low-rectal-polyps-video 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/mesenchymal-stromal-cell-based-therapy-new-perspectives-and-challenges 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/mesenchymal-stromal-cell-based-therapy-new-perspectives-and-challenges 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/mesenchymal-stromal-cell-based-therapy-new-perspectives-and-challenges 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/salvage-radical-prostatectomy-recurrent-prostate-cancer-morbidity-and-functional-outcomes-large 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/fr/salvage-radical-prostatectomy-recurrent-prostate-cancer-morbidity-and-functional-outcomes-large 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/nl/salvage-radical-prostatectomy-recurrent-prostate-cancer-morbidity-and-functional-outcomes-large 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/en/reply-proper-tumor-classification-and-growth-rate-are-key-elements-when-considering-indications-and 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/reply-proper-tumor-classification-and-growth-rate-are-key-elements-when-considering-indications-and 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/reply-proper-tumor-classification-and-growth-rate-are-key-elements-when-considering-indications-and 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/intra-and-interobserver-reproducibility-pancreatic-perfusion-computed-tomography 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/intra-and-interobserver-reproducibility-pancreatic-perfusion-computed-tomography 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/intra-and-interobserver-reproducibility-pancreatic-perfusion-computed-tomography 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/radiation-therapy-young-women-early-breast-cancer-current-state-art 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/radiation-therapy-young-women-early-breast-cancer-current-state-art 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/radiation-therapy-young-women-early-breast-cancer-current-state-art 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/antibody-drug-conjugates-breast-cancer-comprehensive-review 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/antibody-drug-conjugates-breast-cancer-comprehensive-review 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/antibody-drug-conjugates-breast-cancer-comprehensive-review 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/reprogramming-energy-metabolism-increased-expression-and-roles-pyruvate-carboxylase-papillary 2024-04-14T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/reprogramming-energy-metabolism-increased-expression-and-roles-pyruvate-carboxylase-papillary 2024-04-14T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/reprogramming-energy-metabolism-increased-expression-and-roles-pyruvate-carboxylase-papillary 2024-04-14T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/editorial-supportive-care-cancer-patients-constantly-evolving-field 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/editorial-supportive-care-cancer-patients-constantly-evolving-field 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/editorial-supportive-care-cancer-patients-constantly-evolving-field 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/consolidative-thoracic-radiotherapy-stage-iv-small-cell-lung-cancer-selection-patients-amongst 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/consolidative-thoracic-radiotherapy-stage-iv-small-cell-lung-cancer-selection-patients-amongst 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/consolidative-thoracic-radiotherapy-stage-iv-small-cell-lung-cancer-selection-patients-amongst 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/pharmacokinetic-and-exploratory-exposure-response-analysis-pertuzumab-patients-operable-her2 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/pharmacokinetic-and-exploratory-exposure-response-analysis-pertuzumab-patients-operable-her2 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/pharmacokinetic-and-exploratory-exposure-response-analysis-pertuzumab-patients-operable-her2 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/prophylactic-cranial-irradiation-stage-iv-small-cell-lung-cancer-selection-patients-amongst 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/prophylactic-cranial-irradiation-stage-iv-small-cell-lung-cancer-selection-patients-amongst 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/prophylactic-cranial-irradiation-stage-iv-small-cell-lung-cancer-selection-patients-amongst 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/impact-postoperative-inflammatory-biomarkers-oncologic-outcomes-bladder-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/impact-postoperative-inflammatory-biomarkers-oncologic-outcomes-bladder-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/impact-postoperative-inflammatory-biomarkers-oncologic-outcomes-bladder-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/th17-immune-response-adipose-tissue-derived-mesenchymal-stromal-cells 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/th17-immune-response-adipose-tissue-derived-mesenchymal-stromal-cells 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/th17-immune-response-adipose-tissue-derived-mesenchymal-stromal-cells 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/editorial-adjuvant-chemotherapy-rectal-cancer-playing-devil-s-advocate 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/editorial-adjuvant-chemotherapy-rectal-cancer-playing-devil-s-advocate 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/editorial-adjuvant-chemotherapy-rectal-cancer-playing-devil-s-advocate 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/prodige-7-should-be-interpreted-caution 2024-03-10T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/fr/prodige-7-should-be-interpreted-caution 2024-03-10T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/nl/prodige-7-should-be-interpreted-caution 2024-03-10T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/en/erher2-breast-cancer-are-we-really-de-escalating 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/erher2-breast-cancer-are-we-really-de-escalating 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/erher2-breast-cancer-are-we-really-de-escalating 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/role-macrophage-migration-inhibitory-factor-mif-melanoma 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/role-macrophage-migration-inhibitory-factor-mif-melanoma 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/role-macrophage-migration-inhibitory-factor-mif-melanoma 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/pertuzumab-her2-positive-early-breast-cancer-current-use-and-perspectives 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/pertuzumab-her2-positive-early-breast-cancer-current-use-and-perspectives 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/pertuzumab-her2-positive-early-breast-cancer-current-use-and-perspectives 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/ctcs-prognostic-and-predictive-biomarker-stage-iiiii-colon-cancer-companion-study-pepita-trial 2024-04-14T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/ctcs-prognostic-and-predictive-biomarker-stage-iiiii-colon-cancer-companion-study-pepita-trial 2024-04-14T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/ctcs-prognostic-and-predictive-biomarker-stage-iiiii-colon-cancer-companion-study-pepita-trial 2024-04-14T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/correction-pik3ca-genotype-and-pik3ca-mutation-related-gene-signature-and-response-everolimus-and 2024-04-14T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/correction-pik3ca-genotype-and-pik3ca-mutation-related-gene-signature-and-response-everolimus-and 2024-04-14T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/correction-pik3ca-genotype-and-pik3ca-mutation-related-gene-signature-and-response-everolimus-and 2024-04-14T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/mek-and-pd-l1-inhibition-colorectal-cancer-burning-blaze-turning-flash-pan 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/mek-and-pd-l1-inhibition-colorectal-cancer-burning-blaze-turning-flash-pan 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/mek-and-pd-l1-inhibition-colorectal-cancer-burning-blaze-turning-flash-pan 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/health-related-quality-life-older-patients-solid-tumors-and-prognostic-factors-decline 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/health-related-quality-life-older-patients-solid-tumors-and-prognostic-factors-decline 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/health-related-quality-life-older-patients-solid-tumors-and-prognostic-factors-decline 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/assessment-bone-quality-trabecular-bone-score-type-2-diabetes-mellitus-study-frisbee-cohort 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/assessment-bone-quality-trabecular-bone-score-type-2-diabetes-mellitus-study-frisbee-cohort 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/assessment-bone-quality-trabecular-bone-score-type-2-diabetes-mellitus-study-frisbee-cohort 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/lung-cancer-prognosis-intensive-care-depends-mainly-acute-complication 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/lung-cancer-prognosis-intensive-care-depends-mainly-acute-complication 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/lung-cancer-prognosis-intensive-care-depends-mainly-acute-complication 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/update-transarterial-approaches-locoregional-treatment-hepatocellular-carcinoma 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/update-transarterial-approaches-locoregional-treatment-hepatocellular-carcinoma 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/update-transarterial-approaches-locoregional-treatment-hepatocellular-carcinoma 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/molecular-apocrine-tumours-eortc-10994big-1-00-phase-iii-study-pathological-response-after 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/molecular-apocrine-tumours-eortc-10994big-1-00-phase-iii-study-pathological-response-after 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/molecular-apocrine-tumours-eortc-10994big-1-00-phase-iii-study-pathological-response-after 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/quality-management-systemic-treatment-breast-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/quality-management-systemic-treatment-breast-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/quality-management-systemic-treatment-breast-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/breast-cancer-and-pregnancy-related-issues 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/breast-cancer-and-pregnancy-related-issues 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/breast-cancer-and-pregnancy-related-issues 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/oncofertility-counselling-premenopausal-women-her2-positive-breast-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/oncofertility-counselling-premenopausal-women-her2-positive-breast-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/oncofertility-counselling-premenopausal-women-her2-positive-breast-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/circulating-tumor-dna-her2-amplified-breast-cancer-translational-research-substudy-neoaltto-phase 2024-05-05T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/circulating-tumor-dna-her2-amplified-breast-cancer-translational-research-substudy-neoaltto-phase 2024-05-05T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/circulating-tumor-dna-her2-amplified-breast-cancer-translational-research-substudy-neoaltto-phase 2024-05-05T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/position-inhaled-chemotherapy-care-patients-lung-tumors-clinical-feasibility-and-indications 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/position-inhaled-chemotherapy-care-patients-lung-tumors-clinical-feasibility-and-indications 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/position-inhaled-chemotherapy-care-patients-lung-tumors-clinical-feasibility-and-indications 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/microenvironment-tailors-ntreg-structure-and-function 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/fr/microenvironment-tailors-ntreg-structure-and-function 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/nl/microenvironment-tailors-ntreg-structure-and-function 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/en/tumor-dormancy-bedside-late-awakening 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/tumor-dormancy-bedside-late-awakening 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/tumor-dormancy-bedside-late-awakening 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/combining-18f-fdg-petct-based-metabolically-active-tumor-volume-and-circulating-cell-free-dna 2024-04-14T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/combining-18f-fdg-petct-based-metabolically-active-tumor-volume-and-circulating-cell-free-dna 2024-04-14T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/combining-18f-fdg-petct-based-metabolically-active-tumor-volume-and-circulating-cell-free-dna 2024-04-14T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/spindle-cells-aspiration-material-inguinal-adenopathy-possibly-sheep-wolf-s-clothing 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/spindle-cells-aspiration-material-inguinal-adenopathy-possibly-sheep-wolf-s-clothing 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/spindle-cells-aspiration-material-inguinal-adenopathy-possibly-sheep-wolf-s-clothing 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/ovarian-function-and-fertility-preservation-breast-cancer-should-gonadotropin-releasing-hormone 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/ovarian-function-and-fertility-preservation-breast-cancer-should-gonadotropin-releasing-hormone 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/ovarian-function-and-fertility-preservation-breast-cancer-should-gonadotropin-releasing-hormone 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/ossifying-fibromyxoid-tumor-spinal-cord-compression-and-epiduritis 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/ossifying-fibromyxoid-tumor-spinal-cord-compression-and-epiduritis 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/ossifying-fibromyxoid-tumor-spinal-cord-compression-and-epiduritis 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/low-dose-vs-high-dose-cisplatin-lessons-learned-59-chemoradiotherapy-trials-head-and-neck-cancer 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/low-dose-vs-high-dose-cisplatin-lessons-learned-59-chemoradiotherapy-trials-head-and-neck-cancer 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/low-dose-vs-high-dose-cisplatin-lessons-learned-59-chemoradiotherapy-trials-head-and-neck-cancer 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/68ga-psma-petct-based-metastasis-directed-radiotherapy-oligometastatic-prostate-cancer-recurrence 2024-05-05T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/68ga-psma-petct-based-metastasis-directed-radiotherapy-oligometastatic-prostate-cancer-recurrence 2024-05-05T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/68ga-psma-petct-based-metastasis-directed-radiotherapy-oligometastatic-prostate-cancer-recurrence 2024-05-05T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/genomic-transcriptomic-epigenetic-and-immune-profiling-mucinous-breast-cancer 2024-03-10T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/fr/genomic-transcriptomic-epigenetic-and-immune-profiling-mucinous-breast-cancer 2024-03-10T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/nl/genomic-transcriptomic-epigenetic-and-immune-profiling-mucinous-breast-cancer 2024-03-10T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/en/esr1-mutations-metastatic-lobular-breast-cancer-patients 2024-03-31T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/esr1-mutations-metastatic-lobular-breast-cancer-patients 2024-03-31T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/esr1-mutations-metastatic-lobular-breast-cancer-patients 2024-03-31T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/differentiated-type-intraepithelial-neoplasia-lesion-associated-squamous-cell-carcinoma-anus-case 2024-03-10T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/fr/differentiated-type-intraepithelial-neoplasia-lesion-associated-squamous-cell-carcinoma-anus-case 2024-03-10T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/nl/differentiated-type-intraepithelial-neoplasia-lesion-associated-squamous-cell-carcinoma-anus-case 2024-03-10T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/en/post-neoadjuvant-treatment-and-management-residual-disease-breast-cancer-state-art-and-perspectives 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/post-neoadjuvant-treatment-and-management-residual-disease-breast-cancer-state-art-and-perspectives 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/post-neoadjuvant-treatment-and-management-residual-disease-breast-cancer-state-art-and-perspectives 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/evolution-self-perceived-swallowing-function-tongue-strength-and-swallow-related-quality-life 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/evolution-self-perceived-swallowing-function-tongue-strength-and-swallow-related-quality-life 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/evolution-self-perceived-swallowing-function-tongue-strength-and-swallow-related-quality-life 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/human-cd8-cd25-cd127-low-regulatory-t-cells-microrna-signature-and-impact-tgf-ss-and-il-10 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/human-cd8-cd25-cd127-low-regulatory-t-cells-microrna-signature-and-impact-tgf-ss-and-il-10 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/human-cd8-cd25-cd127-low-regulatory-t-cells-microrna-signature-and-impact-tgf-ss-and-il-10 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/plasma-mirna-levels-predicting-therapeutic-response-neoadjuvant-treatment-her2-positive-breast 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/plasma-mirna-levels-predicting-therapeutic-response-neoadjuvant-treatment-her2-positive-breast 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/plasma-mirna-levels-predicting-therapeutic-response-neoadjuvant-treatment-her2-positive-breast 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/cannabinoids-new-approach-pain-control 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/cannabinoids-new-approach-pain-control 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/cannabinoids-new-approach-pain-control 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/brca-gene-mutations-do-not-shape-extent-and-organization-tumor-infiltrating-lymphocytes-triple 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/brca-gene-mutations-do-not-shape-extent-and-organization-tumor-infiltrating-lymphocytes-triple 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/brca-gene-mutations-do-not-shape-extent-and-organization-tumor-infiltrating-lymphocytes-triple 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/immunotherapy-associated-pulmonary-toxicity-biology-behind-clinical-and-radiological-features 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/immunotherapy-associated-pulmonary-toxicity-biology-behind-clinical-and-radiological-features 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/immunotherapy-associated-pulmonary-toxicity-biology-behind-clinical-and-radiological-features 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/multidisciplinary-development-geriatric-core-dataset-clinical-research-older-patients-cancer-french 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/fr/multidisciplinary-development-geriatric-core-dataset-clinical-research-older-patients-cancer-french 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/nl/multidisciplinary-development-geriatric-core-dataset-clinical-research-older-patients-cancer-french 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/en/central-nervous-system-relapse-patients-over-80-years-diffuse-large-b-cell-lymphoma-analysis-two 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/fr/central-nervous-system-relapse-patients-over-80-years-diffuse-large-b-cell-lymphoma-analysis-two 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/nl/central-nervous-system-relapse-patients-over-80-years-diffuse-large-b-cell-lymphoma-analysis-two 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/en/rituximab-plus-lenalidomide-advanced-untreated-follicular-lymphoma 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/fr/rituximab-plus-lenalidomide-advanced-untreated-follicular-lymphoma 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/nl/rituximab-plus-lenalidomide-advanced-untreated-follicular-lymphoma 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/en/long-term-clinical-outcome-and-survivorship-issues-high-grade-bone-sarcomas 2024-04-14T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/long-term-clinical-outcome-and-survivorship-issues-high-grade-bone-sarcomas 2024-04-14T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/long-term-clinical-outcome-and-survivorship-issues-high-grade-bone-sarcomas 2024-04-14T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/sterotactic-body-radiotherapy-sbrt-and-oligometastatic-bladder-cancer-about-case-and-review 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/sterotactic-body-radiotherapy-sbrt-and-oligometastatic-bladder-cancer-about-case-and-review 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/sterotactic-body-radiotherapy-sbrt-and-oligometastatic-bladder-cancer-about-case-and-review 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/quelles-strategies-therapeutiques-pour-les-cbnpc-oligo-metastatiques 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/quelles-strategies-therapeutiques-pour-les-cbnpc-oligo-metastatiques 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/quelles-strategies-therapeutiques-pour-les-cbnpc-oligo-metastatiques 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/conversion-dose-bone-dose-water-radiotherapy-treatment-planning-systems 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/conversion-dose-bone-dose-water-radiotherapy-treatment-planning-systems 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/conversion-dose-bone-dose-water-radiotherapy-treatment-planning-systems 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/family-under-microscope-about-influence-family-ties-through-dna-sibling-routledge 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/family-under-microscope-about-influence-family-ties-through-dna-sibling-routledge 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/family-under-microscope-about-influence-family-ties-through-dna-sibling-routledge 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/trouble-de-l-adaptation-et-trauma-dans-le-dsm-5-implications-diagnostiques-et-pertinence-en 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/trouble-de-l-adaptation-et-trauma-dans-le-dsm-5-implications-diagnostiques-et-pertinence-en 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/trouble-de-l-adaptation-et-trauma-dans-le-dsm-5-implications-diagnostiques-et-pertinence-en 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/frailty-old-age-associated-altered-cytokine-production-response-tlr-ligation-fulop-t-franceschi-c 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/frailty-old-age-associated-altered-cytokine-production-response-tlr-ligation-fulop-t-franceschi-c 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/frailty-old-age-associated-altered-cytokine-production-response-tlr-ligation-fulop-t-franceschi-c 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/calcitonin-and-carcinoembryonic-antigen-diagnosis-and-management-medullary-thyroid-carcinoma-luca 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/calcitonin-and-carcinoembryonic-antigen-diagnosis-and-management-medullary-thyroid-carcinoma-luca 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/calcitonin-and-carcinoembryonic-antigen-diagnosis-and-management-medullary-thyroid-carcinoma-luca 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/desindexation-des-revues-medicales-un-probleme-qui-nous-touche-au-coeur 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/desindexation-des-revues-medicales-un-probleme-qui-nous-touche-au-coeur 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/desindexation-des-revues-medicales-un-probleme-qui-nous-touche-au-coeur 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/c-est-la-rentree 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/c-est-la-rentree 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/c-est-la-rentree 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/nutrition-education-medical-schools-nems-espen-position-paper-0 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/nutrition-education-medical-schools-nems-espen-position-paper 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/nutrition-education-medical-schools-nems-espen-position-paper-0 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/clinical-use-circulating-tumor-cells-ctcs-enumeration-staging-metastatic-breast-cancer-mbc 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/clinical-use-circulating-tumor-cells-ctcs-enumeration-staging-metastatic-breast-cancer-mbc 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/clinical-use-circulating-tumor-cells-ctcs-enumeration-staging-metastatic-breast-cancer-mbc 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/pecoma-talus-unique-case-soft-tissue-tumor-within-bone 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/pecoma-talus-unique-case-soft-tissue-tumor-within-bone 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/pecoma-talus-unique-case-soft-tissue-tumor-within-bone 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/correction-her2-overexpressing-breast-cancers-amplify-fgfr-signaling-upon-acquisition-resistance 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/correction-her2-overexpressing-breast-cancers-amplify-fgfr-signaling-upon-acquisition-resistance 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/correction-her2-overexpressing-breast-cancers-amplify-fgfr-signaling-upon-acquisition-resistance 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/prognostic-value-adipose-tissue-and-muscle-mass-advanced-colorectal-cancer-post-hoc-analysis-two 2024-04-14T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/prognostic-value-adipose-tissue-and-muscle-mass-advanced-colorectal-cancer-post-hoc-analysis-two 2024-04-14T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/prognostic-value-adipose-tissue-and-muscle-mass-advanced-colorectal-cancer-post-hoc-analysis-two 2024-04-14T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/3d-monte-carlo-dosimetry-intraoperative-electron-radiation-therapy-ioert 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/3d-monte-carlo-dosimetry-intraoperative-electron-radiation-therapy-ioert 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/3d-monte-carlo-dosimetry-intraoperative-electron-radiation-therapy-ioert 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/imprint-parity-and-age-first-pregnancy-genomic-landscape-subsequent-breast-cancer 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/imprint-parity-and-age-first-pregnancy-genomic-landscape-subsequent-breast-cancer 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/imprint-parity-and-age-first-pregnancy-genomic-landscape-subsequent-breast-cancer 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/fatal-septic-shock-associated-herpes-simplex-virus-hepatitis-case-report 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/fatal-septic-shock-associated-herpes-simplex-virus-hepatitis-case-report 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/fatal-septic-shock-associated-herpes-simplex-virus-hepatitis-case-report 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/spatially-distinct-tumor-immune-microenvironments-stratify-triple-negative-breast-cancers 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/spatially-distinct-tumor-immune-microenvironments-stratify-triple-negative-breast-cancers 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/spatially-distinct-tumor-immune-microenvironments-stratify-triple-negative-breast-cancers 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/pelvic-salvage-sbrt-radiotherapy-based-68ga-psma-petct-about-case 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/pelvic-salvage-sbrt-radiotherapy-based-68ga-psma-petct-about-case 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/pelvic-salvage-sbrt-radiotherapy-based-68ga-psma-petct-about-case 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/pembrolizumab-plus-trastuzumab-trastuzumab-resistant-advanced-her2-positive-breast-cancer-panacea 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/pembrolizumab-plus-trastuzumab-trastuzumab-resistant-advanced-her2-positive-breast-cancer-panacea 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/pembrolizumab-plus-trastuzumab-trastuzumab-resistant-advanced-her2-positive-breast-cancer-panacea 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/pakt-pathway-activation-associated-pik3ca-mutations-and-good-prognosis-luminal-breast-cancer 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/pakt-pathway-activation-associated-pik3ca-mutations-and-good-prognosis-luminal-breast-cancer 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/pakt-pathway-activation-associated-pik3ca-mutations-and-good-prognosis-luminal-breast-cancer 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/genomic-alterations-breast-cancer-level-evidence-actionability-according-esmo-scale-clinical 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/genomic-alterations-breast-cancer-level-evidence-actionability-according-esmo-scale-clinical 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/genomic-alterations-breast-cancer-level-evidence-actionability-according-esmo-scale-clinical 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/severe-toxicity-checkpoint-protein-inhibitors-what-intensive-care-physicians-need-know 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/severe-toxicity-checkpoint-protein-inhibitors-what-intensive-care-physicians-need-know 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/severe-toxicity-checkpoint-protein-inhibitors-what-intensive-care-physicians-need-know 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/comparative-assessment-clinical-benefit-using-esmo-magnitude-clinical-benefit-scale-version-11-and 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/comparative-assessment-clinical-benefit-using-esmo-magnitude-clinical-benefit-scale-version-11-and 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/comparative-assessment-clinical-benefit-using-esmo-magnitude-clinical-benefit-scale-version-11-and 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/disease-free-survival-surrogate-overall-survival-patients-her2-positive-early-breast-cancer-trials 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/disease-free-survival-surrogate-overall-survival-patients-her2-positive-early-breast-cancer-trials 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/disease-free-survival-surrogate-overall-survival-patients-her2-positive-early-breast-cancer-trials 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/systematic-review-contemporary-management-oligometastatic-prostate-cancer-fighting-challenge-or 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/systematic-review-contemporary-management-oligometastatic-prostate-cancer-fighting-challenge-or 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/systematic-review-contemporary-management-oligometastatic-prostate-cancer-fighting-challenge-or 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/autoimmunity-and-benefit-trastuzumab-treatment-breast-cancer-results-hera-trial 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/autoimmunity-and-benefit-trastuzumab-treatment-breast-cancer-results-hera-trial 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/autoimmunity-and-benefit-trastuzumab-treatment-breast-cancer-results-hera-trial 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/age-related-changes-bach2-and-prdm1-genes-lymphocytes-healthy-donors-and-chronic-lymphocytic 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/age-related-changes-bach2-and-prdm1-genes-lymphocytes-healthy-donors-and-chronic-lymphocytic 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/age-related-changes-bach2-and-prdm1-genes-lymphocytes-healthy-donors-and-chronic-lymphocytic 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/monarch-3-final-pfs-randomized-study-abemaciclib-initial-therapy-advanced-breast-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/monarch-3-final-pfs-randomized-study-abemaciclib-initial-therapy-advanced-breast-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/monarch-3-final-pfs-randomized-study-abemaciclib-initial-therapy-advanced-breast-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/circular-rnome-primary-breast-cancer 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/circular-rnome-primary-breast-cancer 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/circular-rnome-primary-breast-cancer 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/persephone-are-we-ready-de-escalate-adjuvant-trastuzumab-her2-positive-breast-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/persephone-are-we-ready-de-escalate-adjuvant-trastuzumab-her2-positive-breast-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/persephone-are-we-ready-de-escalate-adjuvant-trastuzumab-her2-positive-breast-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/salvage-high-intensity-focused-ultrasound-versus-salvage-radical-prostatectomy-radiation-recurrent 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/salvage-high-intensity-focused-ultrasound-versus-salvage-radical-prostatectomy-radiation-recurrent 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/salvage-high-intensity-focused-ultrasound-versus-salvage-radical-prostatectomy-radiation-recurrent 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/precision-oncology-much-expectations-limitations 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/precision-oncology-much-expectations-limitations 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/precision-oncology-much-expectations-limitations 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/challenge-brain-metastases-non-small-cell-lung-cancer-not-only-economical-issue 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/challenge-brain-metastases-non-small-cell-lung-cancer-not-only-economical-issue 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/challenge-brain-metastases-non-small-cell-lung-cancer-not-only-economical-issue 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/providing-both-autologous-and-allogeneic-hematopoietic-stem-cell-transplants-hsct-may-have-stronger 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/fr/providing-both-autologous-and-allogeneic-hematopoietic-stem-cell-transplants-hsct-may-have-stronger 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/nl/providing-both-autologous-and-allogeneic-hematopoietic-stem-cell-transplants-hsct-may-have-stronger 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/en/immune-checkpoint-blockade-organ-transplant-patients-advanced-cancer-how-far-can-we-go 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/immune-checkpoint-blockade-organ-transplant-patients-advanced-cancer-how-far-can-we-go 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/immune-checkpoint-blockade-organ-transplant-patients-advanced-cancer-how-far-can-we-go 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/transfusion-autologous-and-allogenic-hematopoietic-stem-cell-transplant-guidelines-francophone 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/fr/transfusion-autologous-and-allogenic-hematopoietic-stem-cell-transplant-guidelines-francophone 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/nl/transfusion-autologous-and-allogenic-hematopoietic-stem-cell-transplant-guidelines-francophone 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/en/long-term-follow-phase-3-clinical-trial-inolimomab-treatment-primary-steroid-refractory-agvhd 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/long-term-follow-phase-3-clinical-trial-inolimomab-treatment-primary-steroid-refractory-agvhd 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/long-term-follow-phase-3-clinical-trial-inolimomab-treatment-primary-steroid-refractory-agvhd 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/author-correction-landscape-somatic-mutations-560-breast-cancer-whole-genome-sequences 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/author-correction-landscape-somatic-mutations-560-breast-cancer-whole-genome-sequences 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/author-correction-landscape-somatic-mutations-560-breast-cancer-whole-genome-sequences 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/pathway-level-alterations-rather-mutations-single-genes-predict-response-her2-targeted-therapies 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/pathway-level-alterations-rather-mutations-single-genes-predict-response-her2-targeted-therapies 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/pathway-level-alterations-rather-mutations-single-genes-predict-response-her2-targeted-therapies 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/multicentric-study-accurate-grading-prostate-cancer-systematic-and-mrius-fusion-targeted-biopsies 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/multicentric-study-accurate-grading-prostate-cancer-systematic-and-mrius-fusion-targeted-biopsies 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/multicentric-study-accurate-grading-prostate-cancer-systematic-and-mrius-fusion-targeted-biopsies 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/long-term-health-related-quality-life-critically-ill-patients-haematological-malignancies 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/long-term-health-related-quality-life-critically-ill-patients-haematological-malignancies 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/long-term-health-related-quality-life-critically-ill-patients-haematological-malignancies 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/reciprocal-immuno-biological-alterations-occur-during-co-culture-natural-killer-cells-and-adipose 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/reciprocal-immuno-biological-alterations-occur-during-co-culture-natural-killer-cells-and-adipose 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/reciprocal-immuno-biological-alterations-occur-during-co-culture-natural-killer-cells-and-adipose 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/pik3ca-mutations-are-associated-reduced-pathological-complete-response-rates-primary-her2-positive 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/pik3ca-mutations-are-associated-reduced-pathological-complete-response-rates-primary-her2-positive 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/pik3ca-mutations-are-associated-reduced-pathological-complete-response-rates-primary-her2-positive 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/aldehyde-dehydrogenase-activity-wharton-jelly-mesenchymal-stromal-cells-isolation-and 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/aldehyde-dehydrogenase-activity-wharton-jelly-mesenchymal-stromal-cells-isolation-and 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/aldehyde-dehydrogenase-activity-wharton-jelly-mesenchymal-stromal-cells-isolation-and 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/de-escalating-and-escalating-treatments-early-stage-breast-cancer-st-gallen-international-expert 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/de-escalating-and-escalating-treatments-early-stage-breast-cancer-st-gallen-international-expert 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/de-escalating-and-escalating-treatments-early-stage-breast-cancer-st-gallen-international-expert 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/tumor-infiltrating-lymphocytes-and-prognosis-pooled-individual-patient-analysis-early-stage-triple 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/fr/tumor-infiltrating-lymphocytes-and-prognosis-pooled-individual-patient-analysis-early-stage-triple 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/nl/tumor-infiltrating-lymphocytes-and-prognosis-pooled-individual-patient-analysis-early-stage-triple 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/en/paraganglioma-head-and-neck-region-treated-radiation-therapy-rare-cancer-network-study 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/paraganglioma-head-and-neck-region-treated-radiation-therapy-rare-cancer-network-study 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/paraganglioma-head-and-neck-region-treated-radiation-therapy-rare-cancer-network-study 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/predictive-factors-cancer-associated-thrombosis-large-retrospective-single-center-study 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/predictive-factors-cancer-associated-thrombosis-large-retrospective-single-center-study 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/predictive-factors-cancer-associated-thrombosis-large-retrospective-single-center-study 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/neutropenia-management-patients-receiving-myelosuppressive-polychemotherapy-early-breast-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/neutropenia-management-patients-receiving-myelosuppressive-polychemotherapy-early-breast-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/neutropenia-management-patients-receiving-myelosuppressive-polychemotherapy-early-breast-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/prophylaxis-infections-post-allogeneic-transplantation-guidelines-francophone-society-bone-marrow 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/prophylaxis-infections-post-allogeneic-transplantation-guidelines-francophone-society-bone-marrow 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/prophylaxis-infections-post-allogeneic-transplantation-guidelines-francophone-society-bone-marrow 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/radioembolization-90y-resin-microspheres-neuroendocrine-liver-metastases-international-multicenter 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/radioembolization-90y-resin-microspheres-neuroendocrine-liver-metastases-international-multicenter 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/radioembolization-90y-resin-microspheres-neuroendocrine-liver-metastases-international-multicenter 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/involvement-hpv-infection-release-macrophage-migration-inhibitory-factor-head-and-neck-squamous 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/involvement-hpv-infection-release-macrophage-migration-inhibitory-factor-head-and-neck-squamous 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/involvement-hpv-infection-release-macrophage-migration-inhibitory-factor-head-and-neck-squamous 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/does-use-intraoperative-diclofenac-sodium-increase-postoperative-bleeding-after-prosthetic-breast 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/does-use-intraoperative-diclofenac-sodium-increase-postoperative-bleeding-after-prosthetic-breast 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/does-use-intraoperative-diclofenac-sodium-increase-postoperative-bleeding-after-prosthetic-breast 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/hiatal-hernia-after-oesophagectomy-large-european-survey 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/hiatal-hernia-after-oesophagectomy-large-european-survey 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/hiatal-hernia-after-oesophagectomy-large-european-survey 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/current-imaging-techniques-lymph-node-staging-prostate-cancer-review 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/current-imaging-techniques-lymph-node-staging-prostate-cancer-review 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/current-imaging-techniques-lymph-node-staging-prostate-cancer-review 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/foxp1-negatively-regulates-tumor-infiltrating-lymphocyte-migration-human-breast-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/foxp1-negatively-regulates-tumor-infiltrating-lymphocyte-migration-human-breast-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/foxp1-negatively-regulates-tumor-infiltrating-lymphocyte-migration-human-breast-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/unilateral-adrenalectomy-could-be-valid-option-primary-nodular-adrenal-disease-evidence-twins 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/unilateral-adrenalectomy-could-be-valid-option-primary-nodular-adrenal-disease-evidence-twins 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/unilateral-adrenalectomy-could-be-valid-option-primary-nodular-adrenal-disease-evidence-twins 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/clinical-outcomes-laryngopharyngeal-reflux-treatment-systematic-review-and-meta-analysis 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/clinical-outcomes-laryngopharyngeal-reflux-treatment-systematic-review-and-meta-analysis 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/clinical-outcomes-laryngopharyngeal-reflux-treatment-systematic-review-and-meta-analysis 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/radiation-therapy-resectable-intrathoracic-sarcomas-rare-cancer-network-study 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/radiation-therapy-resectable-intrathoracic-sarcomas-rare-cancer-network-study 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/radiation-therapy-resectable-intrathoracic-sarcomas-rare-cancer-network-study 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/dosimetry-procedure-organs-risk-177lu-peptide-receptor-radionuclide-therapy-patients-neuroendocrine 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/dosimetry-procedure-organs-risk-177lu-peptide-receptor-radionuclide-therapy-patients-neuroendocrine 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/dosimetry-procedure-organs-risk-177lu-peptide-receptor-radionuclide-therapy-patients-neuroendocrine 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/type-i-interferonirf7-axis-instigates-chemotherapy-induced-immunological-dormancy-breast-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/type-i-interferonirf7-axis-instigates-chemotherapy-induced-immunological-dormancy-breast-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/type-i-interferonirf7-axis-instigates-chemotherapy-induced-immunological-dormancy-breast-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/management-young-women-early-breast-cancer 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/fr/management-young-women-early-breast-cancer 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/nl/management-young-women-early-breast-cancer 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/en/intraductal-papillary-neoplasm-bile-duct-rare-precursor-cholangiocarcinoma 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/intraductal-papillary-neoplasm-bile-duct-rare-precursor-cholangiocarcinoma 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/intraductal-papillary-neoplasm-bile-duct-rare-precursor-cholangiocarcinoma 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/cytoreductive-prostatectomy-what-evidence-systematic-review 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/cytoreductive-prostatectomy-what-evidence-systematic-review 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/cytoreductive-prostatectomy-what-evidence-systematic-review 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/chemotherapy-related-cognitive-impairment-mechanisms-clinical-features-and-research-perspectives 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/chemotherapy-related-cognitive-impairment-mechanisms-clinical-features-and-research-perspectives 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/chemotherapy-related-cognitive-impairment-mechanisms-clinical-features-and-research-perspectives 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/haematological-immune-related-adverse-events-induced-anti-pd-1-or-anti-pd-l1-immunotherapy 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/fr/haematological-immune-related-adverse-events-induced-anti-pd-1-or-anti-pd-l1-immunotherapy 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/nl/haematological-immune-related-adverse-events-induced-anti-pd-1-or-anti-pd-l1-immunotherapy 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/en/ovarian-protection-gonadotropin-releasing-hormone-agonists-during-chemotherapy-cancer-patients 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/fr/ovarian-protection-gonadotropin-releasing-hormone-agonists-during-chemotherapy-cancer-patients 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/nl/ovarian-protection-gonadotropin-releasing-hormone-agonists-during-chemotherapy-cancer-patients 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/en/comparison-immediate-vs-deferred-cytoreductive-nephrectomy-patients-synchronous-metastatic-renal 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/comparison-immediate-vs-deferred-cytoreductive-nephrectomy-patients-synchronous-metastatic-renal 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/comparison-immediate-vs-deferred-cytoreductive-nephrectomy-patients-synchronous-metastatic-renal 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/sweet-s-syndrome-induced-pegfilgrastim-during-myelodysplastic-syndrome-areb2-case-report 2024-04-14T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/sweet-s-syndrome-induced-pegfilgrastim-during-myelodysplastic-syndrome-areb2-case-report 2024-04-14T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/sweet-s-syndrome-induced-pegfilgrastim-during-myelodysplastic-syndrome-areb2-case-report 2024-04-14T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/systemic-treatments-thymoma-and-thymic-carcinoma-systematic-review 2024-05-05T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/systemic-treatments-thymoma-and-thymic-carcinoma-systematic-review 2024-05-05T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/systemic-treatments-thymoma-and-thymic-carcinoma-systematic-review 2024-05-05T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/evaluation-medical-board-exam-portugal 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/evaluation-medical-board-exam-portugal 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/evaluation-medical-board-exam-portugal 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/immunological-modulation-following-bone-marrow-derived-mesenchymal-stromal-cells-and-th17 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/immunological-modulation-following-bone-marrow-derived-mesenchymal-stromal-cells-and-th17 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/immunological-modulation-following-bone-marrow-derived-mesenchymal-stromal-cells-and-th17 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/antigen-specificity-and-clinical-significance-igg-and-iga-autoantibodies-produced-situ-tumor 2024-03-10T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/fr/antigen-specificity-and-clinical-significance-igg-and-iga-autoantibodies-produced-situ-tumor 2024-03-10T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/nl/antigen-specificity-and-clinical-significance-igg-and-iga-autoantibodies-produced-situ-tumor 2024-03-10T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/en/determining-clinically-important-differences-health-related-quality-life-older-patients-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/determining-clinically-important-differences-health-related-quality-life-older-patients-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/determining-clinically-important-differences-health-related-quality-life-older-patients-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/cytokinome-adult-derived-human-liver-stemprogenitor-cells-immunological-and-inflammatory-features 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/cytokinome-adult-derived-human-liver-stemprogenitor-cells-immunological-and-inflammatory-features 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/cytokinome-adult-derived-human-liver-stemprogenitor-cells-immunological-and-inflammatory-features 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/pembrolizumab-monotherapy-previously-treated-metastatic-triple-negative-breast-cancer-cohort-phase 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/pembrolizumab-monotherapy-previously-treated-metastatic-triple-negative-breast-cancer-cohort-phase 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/pembrolizumab-monotherapy-previously-treated-metastatic-triple-negative-breast-cancer-cohort-phase 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/adjuvant-letrozole-and-tamoxifen-alone-or-sequentially-postmenopausal-women-hormone-receptor 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/adjuvant-letrozole-and-tamoxifen-alone-or-sequentially-postmenopausal-women-hormone-receptor 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/adjuvant-letrozole-and-tamoxifen-alone-or-sequentially-postmenopausal-women-hormone-receptor 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/hiv-virological-failure-patient-human-t-lymphotropic-virus-type-1-associated-leukemia 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/hiv-virological-failure-patient-human-t-lymphotropic-virus-type-1-associated-leukemia 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/hiv-virological-failure-patient-human-t-lymphotropic-virus-type-1-associated-leukemia 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/decisional-conflict-physicians-during-decision-making-process-simulated-advanced-stage-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/decisional-conflict-physicians-during-decision-making-process-simulated-advanced-stage-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/decisional-conflict-physicians-during-decision-making-process-simulated-advanced-stage-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/achieving-thoracic-oncology-data-collection-europe-precursor-study-35-countries 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/achieving-thoracic-oncology-data-collection-europe-precursor-study-35-countries 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/achieving-thoracic-oncology-data-collection-europe-precursor-study-35-countries 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/anthracycline-and-taxane-based-chemotherapy-versus-docetaxel-and-cyclophosphamide-adjuvant 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/anthracycline-and-taxane-based-chemotherapy-versus-docetaxel-and-cyclophosphamide-adjuvant 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/anthracycline-and-taxane-based-chemotherapy-versus-docetaxel-and-cyclophosphamide-adjuvant 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/sclerosing-encapsulating-peritonitis-potential-complication-cytoreductive-surgery-and-hipec 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/sclerosing-encapsulating-peritonitis-potential-complication-cytoreductive-surgery-and-hipec 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/sclerosing-encapsulating-peritonitis-potential-complication-cytoreductive-surgery-and-hipec 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/empowering-immune-fate-bone-marrow-mesenchymal-stromal-cells-gene-and-protein-changes 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/empowering-immune-fate-bone-marrow-mesenchymal-stromal-cells-gene-and-protein-changes 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/empowering-immune-fate-bone-marrow-mesenchymal-stromal-cells-gene-and-protein-changes 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/white-blood-cell-counts-geriatric-hospitalized-population-poor-diagnostic-marker-infection 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/white-blood-cell-counts-geriatric-hospitalized-population-poor-diagnostic-marker-infection 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/white-blood-cell-counts-geriatric-hospitalized-population-poor-diagnostic-marker-infection 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/risk-factors-development-brain-metastases-patients-her2-positive-breast-cancer 2024-03-31T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/risk-factors-development-brain-metastases-patients-her2-positive-breast-cancer 2024-03-31T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/risk-factors-development-brain-metastases-patients-her2-positive-breast-cancer 2024-03-31T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/training-communication-oncology-clinicians-position-paper-based-third-consensus-meeting-among 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/training-communication-oncology-clinicians-position-paper-based-third-consensus-meeting-among 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/training-communication-oncology-clinicians-position-paper-based-third-consensus-meeting-among 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/smad4-mutation-small-cell-transformation-epidermal-growth-factor-receptor-mutated-lung 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/smad4-mutation-small-cell-transformation-epidermal-growth-factor-receptor-mutated-lung 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/smad4-mutation-small-cell-transformation-epidermal-growth-factor-receptor-mutated-lung 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/reply-v-turan-et-al 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/fr/reply-v-turan-et-al 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/nl/reply-v-turan-et-al 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/en/reply-letter-safety-fertility-preservation-women-breast-cancer 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/fr/reply-letter-safety-fertility-preservation-women-breast-cancer 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/nl/reply-letter-safety-fertility-preservation-women-breast-cancer 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/en/ers-statement-harmonised-standards-lung-cancer-registration-and-lung-cancer-services-europe 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/ers-statement-harmonised-standards-lung-cancer-registration-and-lung-cancer-services-europe 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/ers-statement-harmonised-standards-lung-cancer-registration-and-lung-cancer-services-europe 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/cancer-immunotherapy-associated-hypophysitis 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/cancer-immunotherapy-associated-hypophysitis 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/cancer-immunotherapy-associated-hypophysitis 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/pregnancies-during-and-after-trastuzumab-andor-lapatinib-patients-human-epidermal-growth-factor 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/pregnancies-during-and-after-trastuzumab-andor-lapatinib-patients-human-epidermal-growth-factor 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/pregnancies-during-and-after-trastuzumab-andor-lapatinib-patients-human-epidermal-growth-factor 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/mir302c-sp1-and-nfatc2-regulate-interleukin-21-expression-human-cd4cd45ro-t-lymphocytes 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/mir302c-sp1-and-nfatc2-regulate-interleukin-21-expression-human-cd4cd45ro-t-lymphocytes 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/mir302c-sp1-and-nfatc2-regulate-interleukin-21-expression-human-cd4cd45ro-t-lymphocytes 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/splenic-epithelial-cyst-mistaken-hydatid-cyst-case-report 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/splenic-epithelial-cyst-mistaken-hydatid-cyst-case-report 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/splenic-epithelial-cyst-mistaken-hydatid-cyst-case-report 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/does-type-anesthesia-influence-outcome-after-modular-proximal-mega-prosthesis-bone-metastases-femur 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/does-type-anesthesia-influence-outcome-after-modular-proximal-mega-prosthesis-bone-metastases-femur 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/does-type-anesthesia-influence-outcome-after-modular-proximal-mega-prosthesis-bone-metastases-femur 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/bone-sarcomas-esmo-paedcan-euracan-clinical-practice-guidelines-diagnosis-treatment-and-follow 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/bone-sarcomas-esmo-paedcan-euracan-clinical-practice-guidelines-diagnosis-treatment-and-follow 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/bone-sarcomas-esmo-paedcan-euracan-clinical-practice-guidelines-diagnosis-treatment-and-follow 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/impact-ovarian-function-suppression-premenopausal-women-estrogen-receptor-positive-early-breast 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/impact-ovarian-function-suppression-premenopausal-women-estrogen-receptor-positive-early-breast 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/impact-ovarian-function-suppression-premenopausal-women-estrogen-receptor-positive-early-breast 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/ex-vivo-indocyanine-green-fluorescence-imaging-detection-lymph-node-involvement-advanced-stage 2024-03-31T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/ex-vivo-indocyanine-green-fluorescence-imaging-detection-lymph-node-involvement-advanced-stage 2024-03-31T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/ex-vivo-indocyanine-green-fluorescence-imaging-detection-lymph-node-involvement-advanced-stage 2024-03-31T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/granulocyte-colony-stimulating-factor-and-respiratory-status-critically-ill-neutropenic-patients 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/granulocyte-colony-stimulating-factor-and-respiratory-status-critically-ill-neutropenic-patients 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/granulocyte-colony-stimulating-factor-and-respiratory-status-critically-ill-neutropenic-patients 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/cartography-based-quality-control-prostate-cancer-care-necessary-ground-targeted-focal-therapy 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/cartography-based-quality-control-prostate-cancer-care-necessary-ground-targeted-focal-therapy 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/cartography-based-quality-control-prostate-cancer-care-necessary-ground-targeted-focal-therapy 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/l-editorial-du-redacteur-en-chef 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/l-editorial-du-redacteur-en-chef 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/l-editorial-du-redacteur-en-chef 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/follow-breast-cancer-patients-general-practioner 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/follow-breast-cancer-patients-general-practioner 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/follow-breast-cancer-patients-general-practioner 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/monoclonal-gammopathy-undetermined-significance-when-and-why-look-them 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/fr/monoclonal-gammopathy-undetermined-significance-when-and-why-look-them 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/nl/monoclonal-gammopathy-undetermined-significance-when-and-why-look-them 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/en/malignant-or-benign-hyperleukocytosis 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/fr/malignant-or-benign-hyperleukocytosis 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/nl/malignant-or-benign-hyperleukocytosis 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/en/obinutuzumab-plus-lenalidomide-galen-treatment-relapserefractory-aggressive-lymphoma-phase-ii-lysa 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/fr/obinutuzumab-plus-lenalidomide-galen-treatment-relapserefractory-aggressive-lymphoma-phase-ii-lysa 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/nl/obinutuzumab-plus-lenalidomide-galen-treatment-relapserefractory-aggressive-lymphoma-phase-ii-lysa 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/en/marjolin-s-ulcer-axillary-lymph-node-metastasis 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/marjolin-s-ulcer-axillary-lymph-node-metastasis 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/marjolin-s-ulcer-axillary-lymph-node-metastasis 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/cdk46-inhibitors-neoadjuvant-treatment-breast-cancer-what-can-we-learn 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/cdk46-inhibitors-neoadjuvant-treatment-breast-cancer-what-can-we-learn 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/cdk46-inhibitors-neoadjuvant-treatment-breast-cancer-what-can-we-learn 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/shielding-disk-position-intra-operative-electron-radiotherapy-ioert-monte-carlo-study 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/shielding-disk-position-intra-operative-electron-radiotherapy-ioert-monte-carlo-study 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/shielding-disk-position-intra-operative-electron-radiotherapy-ioert-monte-carlo-study 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/breast-cancer-screening-present-situation-and-prospects 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/breast-cancer-screening-present-situation-and-prospects 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/breast-cancer-screening-present-situation-and-prospects 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/current-efforts-research-pleural-mesothelioma-analysis-clinicaltrialsgov-registry 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/current-efforts-research-pleural-mesothelioma-analysis-clinicaltrialsgov-registry 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/current-efforts-research-pleural-mesothelioma-analysis-clinicaltrialsgov-registry 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/surgical-quality-assurance-head-and-neck-cancer-trials-eortc-head-and-neck-cancer-group-position 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/surgical-quality-assurance-head-and-neck-cancer-trials-eortc-head-and-neck-cancer-group-position 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/surgical-quality-assurance-head-and-neck-cancer-trials-eortc-head-and-neck-cancer-group-position 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/febrile-neutropenia-fn-occurrence-outside-clinical-trials-occurrence-and-predictive-factors-adult 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/febrile-neutropenia-fn-occurrence-outside-clinical-trials-occurrence-and-predictive-factors-adult 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/febrile-neutropenia-fn-occurrence-outside-clinical-trials-occurrence-and-predictive-factors-adult 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/clinical-significance-upper-airway-virus-detection-critically-ill-hematology-patients 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/clinical-significance-upper-airway-virus-detection-critically-ill-hematology-patients 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/clinical-significance-upper-airway-virus-detection-critically-ill-hematology-patients 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/another-step-towards-improving-oncofertility-counselling-young-women-hodgkin-s-lymphoma 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/fr/another-step-towards-improving-oncofertility-counselling-young-women-hodgkin-s-lymphoma 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/nl/another-step-towards-improving-oncofertility-counselling-young-women-hodgkin-s-lymphoma 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/en/minimal-residual-disease-negativity-using-deep-sequencing-major-prognostic-factor-multiple-myeloma 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/fr/minimal-residual-disease-negativity-using-deep-sequencing-major-prognostic-factor-multiple-myeloma 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/nl/minimal-residual-disease-negativity-using-deep-sequencing-major-prognostic-factor-multiple-myeloma 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/en/buparlisib-plus-fulvestrant-versus-placebo-plus-fulvestrant-postmenopausal-hormone-receptor 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/buparlisib-plus-fulvestrant-versus-placebo-plus-fulvestrant-postmenopausal-hormone-receptor 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/buparlisib-plus-fulvestrant-versus-placebo-plus-fulvestrant-postmenopausal-hormone-receptor 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/rare-presentation-igg4-related-disease-gastric-antral-lesion-case-report-and-review-literature 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/rare-presentation-igg4-related-disease-gastric-antral-lesion-case-report-and-review-literature 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/rare-presentation-igg4-related-disease-gastric-antral-lesion-case-report-and-review-literature 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/accuracy-elastic-fusion-biopsy-daily-practice-results-multicenter-study-2115-patients 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/accuracy-elastic-fusion-biopsy-daily-practice-results-multicenter-study-2115-patients 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/accuracy-elastic-fusion-biopsy-daily-practice-results-multicenter-study-2115-patients 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/reply-belkacemi-and-tsoutsou 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/reply-belkacemi-and-tsoutsou 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/reply-belkacemi-and-tsoutsou 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/mesenchymal-stromal-cells-and-natural-killer-cells-complex-story-love-and-hate 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/mesenchymal-stromal-cells-and-natural-killer-cells-complex-story-love-and-hate 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/mesenchymal-stromal-cells-and-natural-killer-cells-complex-story-love-and-hate 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/roadbook-implementation-next-generation-sequencing-clinical-practice-oncology-and-hemato-oncology 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/roadbook-implementation-next-generation-sequencing-clinical-practice-oncology-and-hemato-oncology 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/roadbook-implementation-next-generation-sequencing-clinical-practice-oncology-and-hemato-oncology 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/statistical-analysis-patient-reported-outcome-data-randomised-controlled-trials-locally-advanced 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/statistical-analysis-patient-reported-outcome-data-randomised-controlled-trials-locally-advanced 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/statistical-analysis-patient-reported-outcome-data-randomised-controlled-trials-locally-advanced 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/progress-adjuvant-systemic-therapy-breast-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/progress-adjuvant-systemic-therapy-breast-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/progress-adjuvant-systemic-therapy-breast-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/new-drugs-thoracic-oncology-needs-and-knowledge-online-ers-lung-cancer-assembly-survey 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/new-drugs-thoracic-oncology-needs-and-knowledge-online-ers-lung-cancer-assembly-survey 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/new-drugs-thoracic-oncology-needs-and-knowledge-online-ers-lung-cancer-assembly-survey 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/association-between-phosphodiesterase-type-5-inhibitors-and-prostate-cancer-systematic-review 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/association-between-phosphodiesterase-type-5-inhibitors-and-prostate-cancer-systematic-review 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/association-between-phosphodiesterase-type-5-inhibitors-and-prostate-cancer-systematic-review 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/feasibility-developing-reliable-gene-expression-modules-ffpe-derived-rna-profiled-affymetrix-arrays 2024-04-14T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/feasibility-developing-reliable-gene-expression-modules-ffpe-derived-rna-profiled-affymetrix-arrays 2024-04-14T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/feasibility-developing-reliable-gene-expression-modules-ffpe-derived-rna-profiled-affymetrix-arrays 2024-04-14T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/cdk46-inhibitors-treatment-patients-breast-cancer-summary-multidisciplinary-round-table-discussion 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/cdk46-inhibitors-treatment-patients-breast-cancer-summary-multidisciplinary-round-table-discussion 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/cdk46-inhibitors-treatment-patients-breast-cancer-summary-multidisciplinary-round-table-discussion 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/management-acute-complications-targeted-therapy-patients-cancer-review-cases-managed-icu 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/management-acute-complications-targeted-therapy-patients-cancer-review-cases-managed-icu 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/management-acute-complications-targeted-therapy-patients-cancer-review-cases-managed-icu 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/moving-forward-toward-standardizing-analysis-quality-life-data-randomized-cancer-clinical-trials 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/moving-forward-toward-standardizing-analysis-quality-life-data-randomized-cancer-clinical-trials 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/moving-forward-toward-standardizing-analysis-quality-life-data-randomized-cancer-clinical-trials 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/stratification-pancreatic-ductal-adenocarcinomas-based-tumor-and-microenvironment-features 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/stratification-pancreatic-ductal-adenocarcinomas-based-tumor-and-microenvironment-features 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/stratification-pancreatic-ductal-adenocarcinomas-based-tumor-and-microenvironment-features 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/acquired-resistance-brafi-reverses-senescence-phenotype-mutant-braf-melanoma 2024-03-10T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/fr/acquired-resistance-brafi-reverses-senescence-phenotype-mutant-braf-melanoma 2024-03-10T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/nl/acquired-resistance-brafi-reverses-senescence-phenotype-mutant-braf-melanoma 2024-03-10T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/en/mammaprinttm-comprehensive-review 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/mammaprinttm-comprehensive-review 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/mammaprinttm-comprehensive-review 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/quantifying-tertiary-lymphoid-structure-associated-genes-formalin-fixed-paraffin-embedded-breast 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/quantifying-tertiary-lymphoid-structure-associated-genes-formalin-fixed-paraffin-embedded-breast 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/quantifying-tertiary-lymphoid-structure-associated-genes-formalin-fixed-paraffin-embedded-breast 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/importance-68ga-psma-petct-hospital-practice-view-radiation-oncologist 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/importance-68ga-psma-petct-hospital-practice-view-radiation-oncologist 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/importance-68ga-psma-petct-hospital-practice-view-radiation-oncologist 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/bcy3bcc-2017-survey-physicians-knowledge-attitudes-and-practice-towards-fertility-and-pregnancy 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/bcy3bcc-2017-survey-physicians-knowledge-attitudes-and-practice-towards-fertility-and-pregnancy 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/bcy3bcc-2017-survey-physicians-knowledge-attitudes-and-practice-towards-fertility-and-pregnancy 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/indocyanine-green-fluorescence-imaging-sentinel-lymph-node-detection-colorectal-cancer-systematic 2024-03-10T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/fr/indocyanine-green-fluorescence-imaging-sentinel-lymph-node-detection-colorectal-cancer-systematic 2024-03-10T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/nl/indocyanine-green-fluorescence-imaging-sentinel-lymph-node-detection-colorectal-cancer-systematic 2024-03-10T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/en/tumor-drug-penetration-measurements-could-be-neglected-piece-personalized-cancer-treatment-puzzle 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/tumor-drug-penetration-measurements-could-be-neglected-piece-personalized-cancer-treatment-puzzle 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/tumor-drug-penetration-measurements-could-be-neglected-piece-personalized-cancer-treatment-puzzle 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/tackling-challenges-brain-metastases-solid-tumors 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/tackling-challenges-brain-metastases-solid-tumors 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/tackling-challenges-brain-metastases-solid-tumors 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/adherence-guidelines-requesting-oncotype-dx-publicly-funded-health-care-system 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/fr/adherence-guidelines-requesting-oncotype-dx-publicly-funded-health-care-system 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/nl/adherence-guidelines-requesting-oncotype-dx-publicly-funded-health-care-system 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/en/about-effort-bcrl-trial 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/about-effort-bcrl-trial 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/about-effort-bcrl-trial 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/breast-cancer-diagnosed-during-pregnancy-associated-enrichment-non-silent-mutations-mismatch-repair 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/breast-cancer-diagnosed-during-pregnancy-associated-enrichment-non-silent-mutations-mismatch-repair 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/breast-cancer-diagnosed-during-pregnancy-associated-enrichment-non-silent-mutations-mismatch-repair 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/multidisciplinary-molecular-tumour-board-tool-improve-clinical-practice-and-selection-accrual 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/multidisciplinary-molecular-tumour-board-tool-improve-clinical-practice-and-selection-accrual 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/multidisciplinary-molecular-tumour-board-tool-improve-clinical-practice-and-selection-accrual 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/impact-breast-mri-workup-tumor-size-assessment-and-surgical-planning-patients-early-breast-cancer 2024-03-31T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/impact-breast-mri-workup-tumor-size-assessment-and-surgical-planning-patients-early-breast-cancer 2024-03-31T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/impact-breast-mri-workup-tumor-size-assessment-and-surgical-planning-patients-early-breast-cancer 2024-03-31T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/treatment-outcomes-patients-provenprobable-vs-possible-invasive-mould-disease-phase-iii-trial 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/treatment-outcomes-patients-provenprobable-vs-possible-invasive-mould-disease-phase-iii-trial 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/treatment-outcomes-patients-provenprobable-vs-possible-invasive-mould-disease-phase-iii-trial 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/baseline-hepcidin-measurement-differential-diagnosis-anaemia-elderly-patients-and-its-correlation 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/baseline-hepcidin-measurement-differential-diagnosis-anaemia-elderly-patients-and-its-correlation 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/baseline-hepcidin-measurement-differential-diagnosis-anaemia-elderly-patients-and-its-correlation 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/small-cell-carcinoma-endometrium-clinicopathological-study-and-management-three-cases 2024-03-10T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/fr/small-cell-carcinoma-endometrium-clinicopathological-study-and-management-three-cases 2024-03-10T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/nl/small-cell-carcinoma-endometrium-clinicopathological-study-and-management-three-cases 2024-03-10T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/en/fluorescence-deep-infiltrating-endometriosis-during-laparoscopic-surgery-preliminary-report-6-cases 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/fluorescence-deep-infiltrating-endometriosis-during-laparoscopic-surgery-preliminary-report-6-cases 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/fluorescence-deep-infiltrating-endometriosis-during-laparoscopic-surgery-preliminary-report-6-cases 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/legacy-thomas-tursz-building-leading-comprehensive-cancer-center-europe 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/legacy-thomas-tursz-building-leading-comprehensive-cancer-center-europe 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/legacy-thomas-tursz-building-leading-comprehensive-cancer-center-europe 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/prospective-study-optimize-care-and-improve-knowledge-ovarian-function-andor-fertility-preservation 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/fr/prospective-study-optimize-care-and-improve-knowledge-ovarian-function-andor-fertility-preservation 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/nl/prospective-study-optimize-care-and-improve-knowledge-ovarian-function-andor-fertility-preservation 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/en/90y-petct-based-dosimetry-after-selective-internal-radiation-therapy-predicts-outcome-patients 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/90y-petct-based-dosimetry-after-selective-internal-radiation-therapy-predicts-outcome-patients 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/90y-petct-based-dosimetry-after-selective-internal-radiation-therapy-predicts-outcome-patients 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/potential-benefit-adjuvant-chemotherapy-locally-advanced-rectal-cancer-treated-neoadjuvant 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/potential-benefit-adjuvant-chemotherapy-locally-advanced-rectal-cancer-treated-neoadjuvant 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/potential-benefit-adjuvant-chemotherapy-locally-advanced-rectal-cancer-treated-neoadjuvant 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/therapy-breast-cancer-brain-metastases-challenges-emerging-treatments-and-perspectivesarticle 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/therapy-breast-cancer-brain-metastases-challenges-emerging-treatments-and-perspectivesarticle 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/therapy-breast-cancer-brain-metastases-challenges-emerging-treatments-and-perspectivesarticle 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/scoring-tumor-infiltrating-lymphocytes-visual-estimation-machine-learning 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/fr/scoring-tumor-infiltrating-lymphocytes-visual-estimation-machine-learning 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/nl/scoring-tumor-infiltrating-lymphocytes-visual-estimation-machine-learning 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/en/severe-graves-orbitopathy-occurring-patient-thyroid-hemiagenesis 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/severe-graves-orbitopathy-occurring-patient-thyroid-hemiagenesis 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/severe-graves-orbitopathy-occurring-patient-thyroid-hemiagenesis 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/schwannoma-colon-and-rectum-systematic-literature-review 2024-03-10T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/fr/schwannoma-colon-and-rectum-systematic-literature-review 2024-03-10T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/nl/schwannoma-colon-and-rectum-systematic-literature-review 2024-03-10T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/en/validation-metabolically-active-tumor-volume-and-total-lesion-glycolysis-18f-fdg-petct-derived 2024-04-14T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/validation-metabolically-active-tumor-volume-and-total-lesion-glycolysis-18f-fdg-petct-derived 2024-04-14T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/validation-metabolically-active-tumor-volume-and-total-lesion-glycolysis-18f-fdg-petct-derived 2024-04-14T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/rare-case-hepatotoxicity-geriatrics 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/rare-case-hepatotoxicity-geriatrics 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/rare-case-hepatotoxicity-geriatrics 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/quality-assurance-head-and-neck-surgery-special-considerations-catch 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/quality-assurance-head-and-neck-surgery-special-considerations-catch 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/quality-assurance-head-and-neck-surgery-special-considerations-catch 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/retroperitoneal-mixed-malignant-mullerian-tumor-exceptional-localisation-and-prognosis 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/retroperitoneal-mixed-malignant-mullerian-tumor-exceptional-localisation-and-prognosis 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/retroperitoneal-mixed-malignant-mullerian-tumor-exceptional-localisation-and-prognosis 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/le-mot-du-redac-chef 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/le-mot-du-redac-chef 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/le-mot-du-redac-chef 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/la-casuistique 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/la-casuistique 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/la-casuistique 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/les-actualites-en-medecine-factuelle-edition-2018 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/les-actualites-en-medecine-factuelle-edition-2018 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/les-actualites-en-medecine-factuelle-edition-2018 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/targeting-prohibitin-small-molecules-promote-melanogenesis-and-apoptosis-melanoma-cells 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/targeting-prohibitin-small-molecules-promote-melanogenesis-and-apoptosis-melanoma-cells 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/targeting-prohibitin-small-molecules-promote-melanogenesis-and-apoptosis-melanoma-cells 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/early-postsurgical-temozolomide-treatment-newly-diagnosed-bad-prognosis-glioblastoma-patients 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/early-postsurgical-temozolomide-treatment-newly-diagnosed-bad-prognosis-glioblastoma-patients 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/early-postsurgical-temozolomide-treatment-newly-diagnosed-bad-prognosis-glioblastoma-patients 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/immunity-drives-tet1-regulation-cancer-through-nf-b 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/immunity-drives-tet1-regulation-cancer-through-nf-b 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/immunity-drives-tet1-regulation-cancer-through-nf-b 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/efficacy-hypnosis-based-intervention-improve-well-being-during-cancer-comparison-between-prostate 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/efficacy-hypnosis-based-intervention-improve-well-being-during-cancer-comparison-between-prostate 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/efficacy-hypnosis-based-intervention-improve-well-being-during-cancer-comparison-between-prostate 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/single-agent-parp-inhibitors-treatment-patients-brca-mutated-her2-negative-metastatic-breast-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/single-agent-parp-inhibitors-treatment-patients-brca-mutated-her2-negative-metastatic-breast-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/single-agent-parp-inhibitors-treatment-patients-brca-mutated-her2-negative-metastatic-breast-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/acute-skin-allergy-thermoplastic-mask-used-patient-immobilization-during-radiation-therapy-case 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/acute-skin-allergy-thermoplastic-mask-used-patient-immobilization-during-radiation-therapy-case 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/acute-skin-allergy-thermoplastic-mask-used-patient-immobilization-during-radiation-therapy-case 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/light-chain-iglv3-21-defines-new-poor-prognostic-subgroup-chronic-lymphocytic-leukemia-results 2024-03-31T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/light-chain-iglv3-21-defines-new-poor-prognostic-subgroup-chronic-lymphocytic-leukemia-results 2024-03-31T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/light-chain-iglv3-21-defines-new-poor-prognostic-subgroup-chronic-lymphocytic-leukemia-results 2024-03-31T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/effect-induced-relative-hypoxia-reticulocyte-count-oncological-abdominal-surgery-single-centre 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/effect-induced-relative-hypoxia-reticulocyte-count-oncological-abdominal-surgery-single-centre 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/effect-induced-relative-hypoxia-reticulocyte-count-oncological-abdominal-surgery-single-centre 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/diagnostic-approach-igm-monoclonal-gammopathy-and-clinical-importance-gene-myd88-l265p-mutation 2024-04-14T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/diagnostic-approach-igm-monoclonal-gammopathy-and-clinical-importance-gene-myd88-l265p-mutation 2024-04-14T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/diagnostic-approach-igm-monoclonal-gammopathy-and-clinical-importance-gene-myd88-l265p-mutation 2024-04-14T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/platinum-based-neoadjuvant-chemotherapy-triple-negative-breast-cancer-systematic-review-and-meta 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/platinum-based-neoadjuvant-chemotherapy-triple-negative-breast-cancer-systematic-review-and-meta 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/platinum-based-neoadjuvant-chemotherapy-triple-negative-breast-cancer-systematic-review-and-meta 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/trastuzumab-versus-observation-her2-non-amplified-early-breast-cancer-circulating-tumor-cells-eortc 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/trastuzumab-versus-observation-her2-non-amplified-early-breast-cancer-circulating-tumor-cells-eortc 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/trastuzumab-versus-observation-her2-non-amplified-early-breast-cancer-circulating-tumor-cells-eortc 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/efficacy-anti-her2-agents-combination-adjuvant-or-neoadjuvant-chemotherapy-early-and-locally 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/efficacy-anti-her2-agents-combination-adjuvant-or-neoadjuvant-chemotherapy-early-and-locally 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/efficacy-anti-her2-agents-combination-adjuvant-or-neoadjuvant-chemotherapy-early-and-locally 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/adherence-geriatric-assessment-based-recommendations-older-patients-cancer-multicenter-prospective 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/adherence-geriatric-assessment-based-recommendations-older-patients-cancer-multicenter-prospective 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/adherence-geriatric-assessment-based-recommendations-older-patients-cancer-multicenter-prospective 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/observational-study-prognostic-value-testosterone-and-adiposity-postmenopausal-estrogen-receptor 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/observational-study-prognostic-value-testosterone-and-adiposity-postmenopausal-estrogen-receptor 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/observational-study-prognostic-value-testosterone-and-adiposity-postmenopausal-estrogen-receptor 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/adjuvant-anti-her2-therapy-treatment-related-amenorrhea-and-survival-premenopausal-her2-positive 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/adjuvant-anti-her2-therapy-treatment-related-amenorrhea-and-survival-premenopausal-her2-positive 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/adjuvant-anti-her2-therapy-treatment-related-amenorrhea-and-survival-premenopausal-her2-positive 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/egvhd-app-has-potential-improve-accuracy-graft-versus-host-disease-assessment-multicenter 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/egvhd-app-has-potential-improve-accuracy-graft-versus-host-disease-assessment-multicenter 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/egvhd-app-has-potential-improve-accuracy-graft-versus-host-disease-assessment-multicenter 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/association-t-cell-receptor-repertoire-use-response-combined-trastuzumab-lapatinib-treatment-her2 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/association-t-cell-receptor-repertoire-use-response-combined-trastuzumab-lapatinib-treatment-her2 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/association-t-cell-receptor-repertoire-use-response-combined-trastuzumab-lapatinib-treatment-her2 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/efficacy-chemotherapy-or-chemo-anti-pd-1-combination-after-failed-anti-pd-1-therapy-relapsed-and 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/fr/efficacy-chemotherapy-or-chemo-anti-pd-1-combination-after-failed-anti-pd-1-therapy-relapsed-and 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/nl/efficacy-chemotherapy-or-chemo-anti-pd-1-combination-after-failed-anti-pd-1-therapy-relapsed-and 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/en/neoadjuvant-treatment-future-patients-breast-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/neoadjuvant-treatment-future-patients-breast-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/neoadjuvant-treatment-future-patients-breast-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/are-we-ready-intercultural-cancer-care 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/are-we-ready-intercultural-cancer-care 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/are-we-ready-intercultural-cancer-care 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/gastrointestinal-stromal-tumours-esmo-euracan-clinical-practice-guidelines-diagnosis-treatment-and 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/gastrointestinal-stromal-tumours-esmo-euracan-clinical-practice-guidelines-diagnosis-treatment-and 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/gastrointestinal-stromal-tumours-esmo-euracan-clinical-practice-guidelines-diagnosis-treatment-and 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/primary-hepatic-lymphoma-mimicking-hepatocellular-carcinoma-cirrhotic-patient-case-report-and 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/primary-hepatic-lymphoma-mimicking-hepatocellular-carcinoma-cirrhotic-patient-case-report-and 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/primary-hepatic-lymphoma-mimicking-hepatocellular-carcinoma-cirrhotic-patient-case-report-and 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/assessment-response-chemotherapy-pancreatic-ductal-adenocarcinoma-comparison-between-diffusion 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/assessment-response-chemotherapy-pancreatic-ductal-adenocarcinoma-comparison-between-diffusion 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/assessment-response-chemotherapy-pancreatic-ductal-adenocarcinoma-comparison-between-diffusion 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/what-s-new-systemic-sarcoma-treatments 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/what-s-new-systemic-sarcoma-treatments 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/what-s-new-systemic-sarcoma-treatments 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/soft-tissue-and-visceral-sarcomas-esmo-euracan-clinical-practice-guidelines-diagnosis-treatment-and 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/soft-tissue-and-visceral-sarcomas-esmo-euracan-clinical-practice-guidelines-diagnosis-treatment-and 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/soft-tissue-and-visceral-sarcomas-esmo-euracan-clinical-practice-guidelines-diagnosis-treatment-and 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/icg-fluorescence-imaging-new-tool-optimization-pathological-evaluation-breast-cancer-tumors-after 2024-04-14T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/icg-fluorescence-imaging-new-tool-optimization-pathological-evaluation-breast-cancer-tumors-after 2024-04-14T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/icg-fluorescence-imaging-new-tool-optimization-pathological-evaluation-breast-cancer-tumors-after 2024-04-14T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/unbearable-lightness-therapeutic-algorithms-colorectal-liver-metastasis 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/unbearable-lightness-therapeutic-algorithms-colorectal-liver-metastasis 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/unbearable-lightness-therapeutic-algorithms-colorectal-liver-metastasis 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/supportive-care-cancer-quo-vadis 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/supportive-care-cancer-quo-vadis 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/supportive-care-cancer-quo-vadis 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/reducing-mortality-newly-diagnosed-standard-risk-acute-promyelocytic-leukemia-elderly-patients 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/fr/reducing-mortality-newly-diagnosed-standard-risk-acute-promyelocytic-leukemia-elderly-patients 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/nl/reducing-mortality-newly-diagnosed-standard-risk-acute-promyelocytic-leukemia-elderly-patients 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/en/outcome-patients-perceived-receiving-excessive-care-across-different-ethical-climates-prospective 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/outcome-patients-perceived-receiving-excessive-care-across-different-ethical-climates-prospective 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/outcome-patients-perceived-receiving-excessive-care-across-different-ethical-climates-prospective 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/acute-pancreatitis-following-peptide-receptor-radionuclide-therapy-unusual-adverse-event 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/acute-pancreatitis-following-peptide-receptor-radionuclide-therapy-unusual-adverse-event 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/acute-pancreatitis-following-peptide-receptor-radionuclide-therapy-unusual-adverse-event 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/importance-choice-materials-and-methods-pd-l1-and-til-assessment-oropharyngeal-squamous-cell 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/importance-choice-materials-and-methods-pd-l1-and-til-assessment-oropharyngeal-squamous-cell 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/importance-choice-materials-and-methods-pd-l1-and-til-assessment-oropharyngeal-squamous-cell 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/exploring-positive-surgical-margins-after-minimally-invasive-radical-prostatectomy-does-body 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/exploring-positive-surgical-margins-after-minimally-invasive-radical-prostatectomy-does-body 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/exploring-positive-surgical-margins-after-minimally-invasive-radical-prostatectomy-does-body 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/focal-treatment-unilateral-prostate-cancer-using-hifu-comprehensive-study-pooled-data 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/focal-treatment-unilateral-prostate-cancer-using-hifu-comprehensive-study-pooled-data 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/focal-treatment-unilateral-prostate-cancer-using-hifu-comprehensive-study-pooled-data 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/treatment-advanced-her2-positive-breast-cancer-2018-and-beyond 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/treatment-advanced-her2-positive-breast-cancer-2018-and-beyond 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/treatment-advanced-her2-positive-breast-cancer-2018-and-beyond 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/pseudoadjuvant-chemotherapy-resectable-metastatic-colorectal-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/pseudoadjuvant-chemotherapy-resectable-metastatic-colorectal-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/pseudoadjuvant-chemotherapy-resectable-metastatic-colorectal-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/prm-approach-early-prediction-breast-cancer-response-chemotherapy-based-registered-mr-images 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/prm-approach-early-prediction-breast-cancer-response-chemotherapy-based-registered-mr-images 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/prm-approach-early-prediction-breast-cancer-response-chemotherapy-based-registered-mr-images 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/combination-therapies-treatment-her2-positive-breast-cancer-current-and-future-prospects 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/combination-therapies-treatment-her2-positive-breast-cancer-current-and-future-prospects 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/combination-therapies-treatment-her2-positive-breast-cancer-current-and-future-prospects 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/immunohistochemical-analysis-somatostatin-receptors-endometriosis-tissue-samples-retrospective 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/immunohistochemical-analysis-somatostatin-receptors-endometriosis-tissue-samples-retrospective 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/immunohistochemical-analysis-somatostatin-receptors-endometriosis-tissue-samples-retrospective 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/radiological-evaluation-response-immunotherapy-brain-tumors-where-are-we-now-and-where-are-we-going 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/radiological-evaluation-response-immunotherapy-brain-tumors-where-are-we-now-and-where-are-we-going 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/radiological-evaluation-response-immunotherapy-brain-tumors-where-are-we-now-and-where-are-we-going 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/infusion-bone-marrow-derived-multipotent-mesenchymal-stromal-cells-treatment-steroid-refractory 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/infusion-bone-marrow-derived-multipotent-mesenchymal-stromal-cells-treatment-steroid-refractory 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/infusion-bone-marrow-derived-multipotent-mesenchymal-stromal-cells-treatment-steroid-refractory 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/impact-lenalidomide-maintenance-immune-environment-multiple-myeloma-patients-low-tumor-burden-after 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/fr/impact-lenalidomide-maintenance-immune-environment-multiple-myeloma-patients-low-tumor-burden-after 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/nl/impact-lenalidomide-maintenance-immune-environment-multiple-myeloma-patients-low-tumor-burden-after 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/en/tumor-infiltrating-lymphocytes-patients-receiving-trastuzumabpertuzumab-based-chemotherapy 2024-04-14T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/tumor-infiltrating-lymphocytes-patients-receiving-trastuzumabpertuzumab-based-chemotherapy 2024-04-14T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/tumor-infiltrating-lymphocytes-patients-receiving-trastuzumabpertuzumab-based-chemotherapy 2024-04-14T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/treatment-induced-early-menopause-and-protective-role-gonadotropin-releasing-hormone-agonists 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/fr/treatment-induced-early-menopause-and-protective-role-gonadotropin-releasing-hormone-agonists 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/nl/treatment-induced-early-menopause-and-protective-role-gonadotropin-releasing-hormone-agonists 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/en/gonadotropin-releasing-hormone-agonists-during-chemotherapy-preservation-ovarian-function-and 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/fr/gonadotropin-releasing-hormone-agonists-during-chemotherapy-preservation-ovarian-function-and 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/nl/gonadotropin-releasing-hormone-agonists-during-chemotherapy-preservation-ovarian-function-and 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/en/phase-ib-trial-birabresib-small-molecule-inhibitor-bromodomain-and-extraterminal-proteins-patients 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/phase-ib-trial-birabresib-small-molecule-inhibitor-bromodomain-and-extraterminal-proteins-patients 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/phase-ib-trial-birabresib-small-molecule-inhibitor-bromodomain-and-extraterminal-proteins-patients 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/circulating-tumor-dna-early-response-assessment-and-monitoring-advanced-colorectal-cancer-treated 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/circulating-tumor-dna-early-response-assessment-and-monitoring-advanced-colorectal-cancer-treated 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/circulating-tumor-dna-early-response-assessment-and-monitoring-advanced-colorectal-cancer-treated 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/long-term-follow-2-patients-treated-90y-rituximab-radioimmunotherapy-relapse-nodular-lymphocyte 2024-04-14T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/long-term-follow-2-patients-treated-90y-rituximab-radioimmunotherapy-relapse-nodular-lymphocyte 2024-04-14T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/long-term-follow-2-patients-treated-90y-rituximab-radioimmunotherapy-relapse-nodular-lymphocyte 2024-04-14T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/survivre-au-cancer-du-poumon-detresses-et-resiliences 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/survivre-au-cancer-du-poumon-detresses-et-resiliences 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/survivre-au-cancer-du-poumon-detresses-et-resiliences 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/potential-benefit-intra-operative-administration-ketorolac-breast-cancer-recurrence-according 2024-03-10T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/fr/potential-benefit-intra-operative-administration-ketorolac-breast-cancer-recurrence-according 2024-03-10T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/nl/potential-benefit-intra-operative-administration-ketorolac-breast-cancer-recurrence-according 2024-03-10T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/en/une-nouvelle-etoile-au-firmament-scientifique 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/une-nouvelle-etoile-au-firmament-scientifique 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/une-nouvelle-etoile-au-firmament-scientifique 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/concept-oligometastases-colorectal-cancer-clinical-evidences-new-therapeutic-strategies 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/concept-oligometastases-colorectal-cancer-clinical-evidences-new-therapeutic-strategies 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/concept-oligometastases-colorectal-cancer-clinical-evidences-new-therapeutic-strategies 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/published-erratum-2016-pik3ca-mutations-are-associated-reduced-pathological-complete-response-rates 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/published-erratum-2016-pik3ca-mutations-are-associated-reduced-pathological-complete-response-rates 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/published-erratum-2016-pik3ca-mutations-are-associated-reduced-pathological-complete-response-rates 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/erratum-pathway-level-alterations-rather-mutations-single-genes-predict-response-her2-targeted 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/erratum-pathway-level-alterations-rather-mutations-single-genes-predict-response-her2-targeted 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/erratum-pathway-level-alterations-rather-mutations-single-genes-predict-response-her2-targeted 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/dose-response-choroidal-melanoma 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/dose-response-choroidal-melanoma 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/dose-response-choroidal-melanoma 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/18fdg-petct-and-molecular-markers-predict-response-neoadjuvant-chemotherapy-and-outcome-her2 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/18fdg-petct-and-molecular-markers-predict-response-neoadjuvant-chemotherapy-and-outcome-her2 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/18fdg-petct-and-molecular-markers-predict-response-neoadjuvant-chemotherapy-and-outcome-her2 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/change-topoisomerase-1-top1-positive-circulating-tumor-cells-impacts-overall-survival-patients 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/change-topoisomerase-1-top1-positive-circulating-tumor-cells-impacts-overall-survival-patients 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/change-topoisomerase-1-top1-positive-circulating-tumor-cells-impacts-overall-survival-patients 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/tumor-metabolism-assessed-fdg-petct-and-tumor-proliferation-assessed-genomic-grade-index-predict 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/tumor-metabolism-assessed-fdg-petct-and-tumor-proliferation-assessed-genomic-grade-index-predict 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/tumor-metabolism-assessed-fdg-petct-and-tumor-proliferation-assessed-genomic-grade-index-predict 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/european-organisation-research-and-treatment-cancer-soft-tissue-and-bone-sarcoma-group-experience 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/european-organisation-research-and-treatment-cancer-soft-tissue-and-bone-sarcoma-group-experience 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/european-organisation-research-and-treatment-cancer-soft-tissue-and-bone-sarcoma-group-experience 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/reply-esmo-mcbs-v11-statistical-and-patient-relevant-shortcomings-r-emprechtinger-et-al 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/reply-esmo-mcbs-v11-statistical-and-patient-relevant-shortcomings-r-emprechtinger-et-al 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/reply-esmo-mcbs-v11-statistical-and-patient-relevant-shortcomings-r-emprechtinger-et-al 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/circulating-tumor-cells-breast-cancer-patients-treated-neoadjuvant-chemotherapy-meta-analysis 2024-04-14T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/circulating-tumor-cells-breast-cancer-patients-treated-neoadjuvant-chemotherapy-meta-analysis 2024-04-14T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/circulating-tumor-cells-breast-cancer-patients-treated-neoadjuvant-chemotherapy-meta-analysis 2024-04-14T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/dual-jak1-and-stat3-mutations-breast-implant-associated-anaplastic-large-cell-lymphoma 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/dual-jak1-and-stat3-mutations-breast-implant-associated-anaplastic-large-cell-lymphoma 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/dual-jak1-and-stat3-mutations-breast-implant-associated-anaplastic-large-cell-lymphoma 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/impact-tumor-cell-metabolism-t-cell-mediated-immune-responses-and-immuno-metabolic-biomarkers 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/impact-tumor-cell-metabolism-t-cell-mediated-immune-responses-and-immuno-metabolic-biomarkers 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/impact-tumor-cell-metabolism-t-cell-mediated-immune-responses-and-immuno-metabolic-biomarkers 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/controversies-oncology-which-adjuvant-endocrine-therapy-be-given-premenopausal-patients-hormone 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/controversies-oncology-which-adjuvant-endocrine-therapy-be-given-premenopausal-patients-hormone 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/controversies-oncology-which-adjuvant-endocrine-therapy-be-given-premenopausal-patients-hormone 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/effect-ccl5-expression-recruitment-immune-cells-triple-negative-breast-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/effect-ccl5-expression-recruitment-immune-cells-triple-negative-breast-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/effect-ccl5-expression-recruitment-immune-cells-triple-negative-breast-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/use-lymphoscintigraphy-differentiate-primary-versus-secondary-lower-extremity-lymphedema-after 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/use-lymphoscintigraphy-differentiate-primary-versus-secondary-lower-extremity-lymphedema-after 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/use-lymphoscintigraphy-differentiate-primary-versus-secondary-lower-extremity-lymphedema-after 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/celyad-s-novel-car-t-cell-therapy-solid-malignancies 2024-03-10T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/fr/celyad-s-novel-car-t-cell-therapy-solid-malignancies 2024-03-10T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/nl/celyad-s-novel-car-t-cell-therapy-solid-malignancies 2024-03-10T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/en/estro-acrop-guidelines-target-volume-definition-treatment-locally-advanced-non-small-cell-lung 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/estro-acrop-guidelines-target-volume-definition-treatment-locally-advanced-non-small-cell-lung 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/estro-acrop-guidelines-target-volume-definition-treatment-locally-advanced-non-small-cell-lung 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/evolution-and-revolution-systemic-treatment-lung-cancer-new-role-immunotherapy 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/evolution-and-revolution-systemic-treatment-lung-cancer-new-role-immunotherapy 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/evolution-and-revolution-systemic-treatment-lung-cancer-new-role-immunotherapy 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/foreskin-derived-mesenchymal-stromal-cells-aldehyde-dehydrogenase-activity-isolation-and-gene 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/foreskin-derived-mesenchymal-stromal-cells-aldehyde-dehydrogenase-activity-isolation-and-gene 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/foreskin-derived-mesenchymal-stromal-cells-aldehyde-dehydrogenase-activity-isolation-and-gene 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/advanced-glycation-end-products-c-type-lectin-and-cysteinyl-leukotriene-receptors-distinct 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/advanced-glycation-end-products-c-type-lectin-and-cysteinyl-leukotriene-receptors-distinct 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/advanced-glycation-end-products-c-type-lectin-and-cysteinyl-leukotriene-receptors-distinct 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/reply-letter-body-mass-index-and-clinical-outcomes-trastuzumab-treated-metastatic-breast-cancer 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/fr/reply-letter-body-mass-index-and-clinical-outcomes-trastuzumab-treated-metastatic-breast-cancer 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/nl/reply-letter-body-mass-index-and-clinical-outcomes-trastuzumab-treated-metastatic-breast-cancer 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/en/total-choline-quantification-measured-1h-mr-spectroscopy-early-predictor-response-after-neoadjuvant 2024-03-31T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/total-choline-quantification-measured-1h-mr-spectroscopy-early-predictor-response-after-neoadjuvant 2024-03-31T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/total-choline-quantification-measured-1h-mr-spectroscopy-early-predictor-response-after-neoadjuvant 2024-03-31T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/feasibility-study-adaptive-18f-fdg-pet-guided-radiotherapy-recurrent-and-second-primary-head-and 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/feasibility-study-adaptive-18f-fdg-pet-guided-radiotherapy-recurrent-and-second-primary-head-and 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/feasibility-study-adaptive-18f-fdg-pet-guided-radiotherapy-recurrent-and-second-primary-head-and 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/tsunami-immunotherapy-will-soft-tissue-sarcoma-remain-immune-desert 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/tsunami-immunotherapy-will-soft-tissue-sarcoma-remain-immune-desert 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/tsunami-immunotherapy-will-soft-tissue-sarcoma-remain-immune-desert 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/pdz-domain-binding-motif-tax-sustains-t-cell-proliferation-htlv-1-infected-humanized-mice 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/pdz-domain-binding-motif-tax-sustains-t-cell-proliferation-htlv-1-infected-humanized-mice 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/pdz-domain-binding-motif-tax-sustains-t-cell-proliferation-htlv-1-infected-humanized-mice 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/thyroid-autoimmunity-and-intracytoplasmic-sperm-injection-outcome-systematic-review-and-meta 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/thyroid-autoimmunity-and-intracytoplasmic-sperm-injection-outcome-systematic-review-and-meta 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/thyroid-autoimmunity-and-intracytoplasmic-sperm-injection-outcome-systematic-review-and-meta 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/association-p27-and-cyclin-d1-expression-and-benefit-adjuvant-trastuzumab-treatment-her2-positive 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/association-p27-and-cyclin-d1-expression-and-benefit-adjuvant-trastuzumab-treatment-her2-positive 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/association-p27-and-cyclin-d1-expression-and-benefit-adjuvant-trastuzumab-treatment-her2-positive 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/high-infiltration-cd68-macrophages-associated-poor-prognoses-head-and-neck-squamous-cell-carcinoma 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/high-infiltration-cd68-macrophages-associated-poor-prognoses-head-and-neck-squamous-cell-carcinoma 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/high-infiltration-cd68-macrophages-associated-poor-prognoses-head-and-neck-squamous-cell-carcinoma 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/postmastectomy-radiation-therapy-women-t1-t2-tumors-and-1-3-positive-lymph-nodes-analysis-breast 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/postmastectomy-radiation-therapy-women-t1-t2-tumors-and-1-3-positive-lymph-nodes-analysis-breast 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/postmastectomy-radiation-therapy-women-t1-t2-tumors-and-1-3-positive-lymph-nodes-analysis-breast 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/la-psychiatrie-en-evolution-rapide-et-permanente 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/la-psychiatrie-en-evolution-rapide-et-permanente 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/la-psychiatrie-en-evolution-rapide-et-permanente 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/unusual-presentation-hepatocellular-carcinoma-potential-late-side-effect-radiotherapy-patient 2024-05-05T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/unusual-presentation-hepatocellular-carcinoma-potential-late-side-effect-radiotherapy-patient 2024-05-05T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/unusual-presentation-hepatocellular-carcinoma-potential-late-side-effect-radiotherapy-patient 2024-05-05T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/revue-medicale-de-bruxelles-nouveautes-et-changement-pour-2018 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/revue-medicale-de-bruxelles-nouveautes-et-changement-pour-2018 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/revue-medicale-de-bruxelles-nouveautes-et-changement-pour-2018 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/re-magnitude-clinical-benefit-cancer-drugs-approved-us-food-and-drug-administration 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/re-magnitude-clinical-benefit-cancer-drugs-approved-us-food-and-drug-administration 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/re-magnitude-clinical-benefit-cancer-drugs-approved-us-food-and-drug-administration 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/deep-inferior-epigastric-perforator-flap-diep-breast-reconstruction-impact-intraoperative 2024-03-10T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/fr/deep-inferior-epigastric-perforator-flap-diep-breast-reconstruction-impact-intraoperative 2024-03-10T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/nl/deep-inferior-epigastric-perforator-flap-diep-breast-reconstruction-impact-intraoperative 2024-03-10T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/en/thyroid-follicular-adenomas-and-carcinomas-molecular-profiling-provides-evidence-continuous 2024-04-14T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/thyroid-follicular-adenomas-and-carcinomas-molecular-profiling-provides-evidence-continuous 2024-04-14T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/thyroid-follicular-adenomas-and-carcinomas-molecular-profiling-provides-evidence-continuous 2024-04-14T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/phase-iii-randomised-study-comparing-concomitant-radiochemotherapy-cisplatin-and-docetaxel 2024-05-05T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/phase-iii-randomised-study-comparing-concomitant-radiochemotherapy-cisplatin-and-docetaxel 2024-05-05T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/phase-iii-randomised-study-comparing-concomitant-radiochemotherapy-cisplatin-and-docetaxel 2024-05-05T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/tumor-pik3ca-genotype-and-prognosis-early-stage-breast-cancer-pooled-analysis-individual-patient 2024-04-14T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/tumor-pik3ca-genotype-and-prognosis-early-stage-breast-cancer-pooled-analysis-individual-patient 2024-04-14T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/tumor-pik3ca-genotype-and-prognosis-early-stage-breast-cancer-pooled-analysis-individual-patient 2024-04-14T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/impact-routine-brain-imaging-initial-management-lung-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/impact-routine-brain-imaging-initial-management-lung-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/impact-routine-brain-imaging-initial-management-lung-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/immunotherapy-new-standard-care-thoracic-malignancies-summary-european-respiratory-society-research 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/immunotherapy-new-standard-care-thoracic-malignancies-summary-european-respiratory-society-research 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/immunotherapy-new-standard-care-thoracic-malignancies-summary-european-respiratory-society-research 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/endocrine-therapy-and-palbociclib-within-compassionate-use-program-heavily-pretreated-hormone 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/endocrine-therapy-and-palbociclib-within-compassionate-use-program-heavily-pretreated-hormone 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/endocrine-therapy-and-palbociclib-within-compassionate-use-program-heavily-pretreated-hormone 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/endothelial-cell-specific-molecule-1-critically-ill-patients-hematologic-malignancy 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/endothelial-cell-specific-molecule-1-critically-ill-patients-hematologic-malignancy 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/endothelial-cell-specific-molecule-1-critically-ill-patients-hematologic-malignancy 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/immunological-impact-wharton-s-jelly-mesenchymal-stromal-cells-and-natural-killer-cell-co-culture 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/immunological-impact-wharton-s-jelly-mesenchymal-stromal-cells-and-natural-killer-cell-co-culture 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/immunological-impact-wharton-s-jelly-mesenchymal-stromal-cells-and-natural-killer-cell-co-culture 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/enzalutamide-treatment-androgen-receptor-expressing-triple-negative-breast-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/enzalutamide-treatment-androgen-receptor-expressing-triple-negative-breast-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/enzalutamide-treatment-androgen-receptor-expressing-triple-negative-breast-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/ethical-decision-making-climate-icu-theoretical-framework-and-validation-self-assessment-tool 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/ethical-decision-making-climate-icu-theoretical-framework-and-validation-self-assessment-tool 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/ethical-decision-making-climate-icu-theoretical-framework-and-validation-self-assessment-tool 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/immuno-oncology-101-overview-major-concepts-and-translational-perspectives 2024-03-10T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/fr/immuno-oncology-101-overview-major-concepts-and-translational-perspectives 2024-03-10T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/nl/immuno-oncology-101-overview-major-concepts-and-translational-perspectives 2024-03-10T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/en/immune-checkpoint-inhibitors-antibodies-pd1-and-pd-l1-new-therapeutic-weapon-against-non-small-cell 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/immune-checkpoint-inhibitors-antibodies-pd1-and-pd-l1-new-therapeutic-weapon-against-non-small-cell 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/immune-checkpoint-inhibitors-antibodies-pd1-and-pd-l1-new-therapeutic-weapon-against-non-small-cell 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/diversity-brain-metastases-screening-and-management-non-small-cell-lung-cancer-europe-results 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/diversity-brain-metastases-screening-and-management-non-small-cell-lung-cancer-europe-results 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/diversity-brain-metastases-screening-and-management-non-small-cell-lung-cancer-europe-results 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/pertuzumab-and-trastuzumab-or-without-metronomic-chemotherapy-older-patients-her2-positive 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/pertuzumab-and-trastuzumab-or-without-metronomic-chemotherapy-older-patients-her2-positive 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/pertuzumab-and-trastuzumab-or-without-metronomic-chemotherapy-older-patients-her2-positive 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/surgery-primary-tumour-patients-presenting-de-novo-metastatic-breast-cancer-do-or-not-do 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/surgery-primary-tumour-patients-presenting-de-novo-metastatic-breast-cancer-do-or-not-do 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/surgery-primary-tumour-patients-presenting-de-novo-metastatic-breast-cancer-do-or-not-do 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/sequential-injection-radioactive-nanosized-colloids-followed-indocyanine-green-sentinel-lymph-node 2024-05-05T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/sequential-injection-radioactive-nanosized-colloids-followed-indocyanine-green-sentinel-lymph-node 2024-05-05T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/sequential-injection-radioactive-nanosized-colloids-followed-indocyanine-green-sentinel-lymph-node 2024-05-05T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/immune-infiltration-invasive-lobular-breast-cancer 2024-03-31T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/immune-infiltration-invasive-lobular-breast-cancer 2024-03-31T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/immune-infiltration-invasive-lobular-breast-cancer 2024-03-31T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/epigenetic-modifiers-new-immunomodulatory-therapies-solid-tumours 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/epigenetic-modifiers-new-immunomodulatory-therapies-solid-tumours 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/epigenetic-modifiers-new-immunomodulatory-therapies-solid-tumours 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/esmo-leaders-generation-programme-alumni-insight 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/fr/esmo-leaders-generation-programme-alumni-insight 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/nl/esmo-leaders-generation-programme-alumni-insight 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/en/selective-internal-radiation-therapy-sirt-partial-hepatectomy-or-radiofrequency-destruction 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/selective-internal-radiation-therapy-sirt-partial-hepatectomy-or-radiofrequency-destruction 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/selective-internal-radiation-therapy-sirt-partial-hepatectomy-or-radiofrequency-destruction 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/genomic-hotspots-few-recurrent-fusion-genes-breast-cancer 2024-03-31T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/genomic-hotspots-few-recurrent-fusion-genes-breast-cancer 2024-03-31T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/genomic-hotspots-few-recurrent-fusion-genes-breast-cancer 2024-03-31T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/t-cell-depleted-haploidentical-stem-cell-transplantation-results-improve-time-adults-acute-leukemia 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/t-cell-depleted-haploidentical-stem-cell-transplantation-results-improve-time-adults-acute-leukemia 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/t-cell-depleted-haploidentical-stem-cell-transplantation-results-improve-time-adults-acute-leukemia 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/natural-anti-estrogen-receptor-alpha-antibodies-able-induce-estrogenic-responses-breast-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/natural-anti-estrogen-receptor-alpha-antibodies-able-induce-estrogenic-responses-breast-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/natural-anti-estrogen-receptor-alpha-antibodies-able-induce-estrogenic-responses-breast-cancer 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/first-line-treatment-helicobacter-pylori-lebanon-comparison-bismuth-containing-quadruple-therapy 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/first-line-treatment-helicobacter-pylori-lebanon-comparison-bismuth-containing-quadruple-therapy 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/first-line-treatment-helicobacter-pylori-lebanon-comparison-bismuth-containing-quadruple-therapy 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/abscopal-effect-era-cancer-immunotherapy-spontaneous-synergism-boosting-anti-tumor-immunity 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/abscopal-effect-era-cancer-immunotherapy-spontaneous-synergism-boosting-anti-tumor-immunity 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/abscopal-effect-era-cancer-immunotherapy-spontaneous-synergism-boosting-anti-tumor-immunity 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/capecitabine-efficacy-correlated-tymp-and-rb-expression-pdx-established-triple-negative-breast 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/capecitabine-efficacy-correlated-tymp-and-rb-expression-pdx-established-triple-negative-breast 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/capecitabine-efficacy-correlated-tymp-and-rb-expression-pdx-established-triple-negative-breast 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/radiotherapy-locally-advanced-non-small-lung-cancer-including-combined-modality-iaslc-thoracic 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/radiotherapy-locally-advanced-non-small-lung-cancer-including-combined-modality-iaslc-thoracic 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/radiotherapy-locally-advanced-non-small-lung-cancer-including-combined-modality-iaslc-thoracic 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/les-nouvelles-techniques-de-radiotherapie 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/les-nouvelles-techniques-de-radiotherapie 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/les-nouvelles-techniques-de-radiotherapie 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/new-therapeutic-approaches-cutaneous-t-cell-lymphomas 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/fr/new-therapeutic-approaches-cutaneous-t-cell-lymphomas 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/nl/new-therapeutic-approaches-cutaneous-t-cell-lymphomas 2024-03-03T07:00:03+01:00 0.5 https://bordet.makemeweb.dev/en/nouvelles-promesses-de-l-immunotherapie-pour-les-carcinomes-epidermoides-de-la-tete-et-du-cou-entre 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/nouvelles-promesses-de-l-immunotherapie-pour-les-carcinomes-epidermoides-de-la-tete-et-du-cou-entre 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/nouvelles-promesses-de-l-immunotherapie-pour-les-carcinomes-epidermoides-de-la-tete-et-du-cou-entre 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/immunology-solid-tumors-beyond-tumor-infiltrating-lymphocytes-role-tertiary-lymphoid-structures 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/immunology-solid-tumors-beyond-tumor-infiltrating-lymphocytes-role-tertiary-lymphoid-structures 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/immunology-solid-tumors-beyond-tumor-infiltrating-lymphocytes-role-tertiary-lymphoid-structures 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/brain-metastases-unusual-dissemination-heterologous-carcinosarcoma-uterus 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/brain-metastases-unusual-dissemination-heterologous-carcinosarcoma-uterus 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/brain-metastases-unusual-dissemination-heterologous-carcinosarcoma-uterus 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/systemic-chemotherapy-regimens-early-breast-cancer-patients-updated-recommendations-bsmo-breast 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/systemic-chemotherapy-regimens-early-breast-cancer-patients-updated-recommendations-bsmo-breast 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/systemic-chemotherapy-regimens-early-breast-cancer-patients-updated-recommendations-bsmo-breast 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/career-opportunities-and-benefits-young-oncologists-european-society-medical-oncology-esmo 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/career-opportunities-and-benefits-young-oncologists-european-society-medical-oncology-esmo 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/career-opportunities-and-benefits-young-oncologists-european-society-medical-oncology-esmo 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/extra-osseous-ewing-sarcoma-thyroid-gland-mimicking-hemorrhagic-cyst-hashimoto-thyroiditis 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/extra-osseous-ewing-sarcoma-thyroid-gland-mimicking-hemorrhagic-cyst-hashimoto-thyroiditis 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/extra-osseous-ewing-sarcoma-thyroid-gland-mimicking-hemorrhagic-cyst-hashimoto-thyroiditis 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/56-years-old-old-age-pure-seminomatous-germ-cell-tumor-case-report-and-review-literature 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/56-years-old-old-age-pure-seminomatous-germ-cell-tumor-case-report-and-review-literature 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/56-years-old-old-age-pure-seminomatous-germ-cell-tumor-case-report-and-review-literature 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/paratesticular-liposarcoma-unsual-presentation-testicular-mass 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/paratesticular-liposarcoma-unsual-presentation-testicular-mass 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/paratesticular-liposarcoma-unsual-presentation-testicular-mass 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/lymphatic-drainage-deep-inferior-epigastric-artery-perforator-flap-after-breast-reconstruction 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/lymphatic-drainage-deep-inferior-epigastric-artery-perforator-flap-after-breast-reconstruction 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/lymphatic-drainage-deep-inferior-epigastric-artery-perforator-flap-after-breast-reconstruction 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/corps-en-souffrance-psychismes-en-presence-editions-eres-collection-serie-cancers-psys-184-p 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/corps-en-souffrance-psychismes-en-presence-editions-eres-collection-serie-cancers-psys-184-p 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/corps-en-souffrance-psychismes-en-presence-editions-eres-collection-serie-cancers-psys-184-p 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/communicating-relativbes-cacer-care-oxford-textbook-communication-oncology-and-palliative-care-103 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/communicating-relativbes-cacer-care-oxford-textbook-communication-oncology-and-palliative-care-103 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/communicating-relativbes-cacer-care-oxford-textbook-communication-oncology-and-palliative-care-103 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/belgian-experience-communication-skills-training-oxford-textbook-communication-oncology-and 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/belgian-experience-communication-skills-training-oxford-textbook-communication-oncology-and 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/belgian-experience-communication-skills-training-oxford-textbook-communication-oncology-and 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/development-lacomm-10-french-medical-communication-analysis-software-study-assessing-its 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/development-lacomm-10-french-medical-communication-analysis-software-study-assessing-its 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/development-lacomm-10-french-medical-communication-analysis-software-study-assessing-its 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/durable-clinical-benefit-nivolumab-plus-ipilimumab-dna-mismatch-repair-deficientmicrosatellite 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/fr/durable-clinical-benefit-nivolumab-plus-ipilimumab-dna-mismatch-repair-deficientmicrosatellite 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/nl/durable-clinical-benefit-nivolumab-plus-ipilimumab-dna-mismatch-repair-deficientmicrosatellite 2024-04-21T07:00:04+02:00 0.5 https://bordet.makemeweb.dev/en/mesenchymal-stromal-cells-bone-marrow-and-natural-killer-cells-cell-interactions-and-cross 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/mesenchymal-stromal-cells-bone-marrow-and-natural-killer-cells-cell-interactions-and-cross 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/mesenchymal-stromal-cells-bone-marrow-and-natural-killer-cells-cell-interactions-and-cross 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/activity-and-safety-afatinib-window-pre-operative-eortc-study-patients-squamous-cell-carcinoma-head 2024-03-31T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/activity-and-safety-afatinib-window-pre-operative-eortc-study-patients-squamous-cell-carcinoma-head 2024-03-31T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/activity-and-safety-afatinib-window-pre-operative-eortc-study-patients-squamous-cell-carcinoma-head 2024-03-31T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/unravelling-triple-negative-breast-cancer-molecular-heterogeneity-using-integrative-multiomic 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/fr/unravelling-triple-negative-breast-cancer-molecular-heterogeneity-using-integrative-multiomic 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/nl/unravelling-triple-negative-breast-cancer-molecular-heterogeneity-using-integrative-multiomic 2024-04-28T07:00:03+02:00 0.5 https://bordet.makemeweb.dev/en/insights-inflammatory-priming-mesenchymal-stromal-cells-functional-biological-impacts 2024-04-21T07:00:04+02:00 0.5